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A key development for our understanding of the mechanisms that control gene
expression has been the finding that the histones recruit proteins with effector functions
to chromatin. This is mediated primarily by post-translational modifications that occur on
the histone N-terminal domains (“tails”). Single or combinations of histone tail
modifications serve as scaffolds for protein complexes controlling transcription or cotranscriptional processes, thus impacting gene expression. Histone tail modifications are
regulated by multiple, often overlapping pathways in the cell, and as such, present an
important regulatory “node” through which the cell is able to integrate and respond to
environmental signals. However, a consequence of this is that any artificial or naturally
occurring molecule that “mimics” the histone tails has the potential to strongly impact
gene function and the cell’s response to the environment.
Indeed, we were able to identify a novel pathway exploited by the influenza virus
to directly dampen the host transcriptional response. The non-structural protein 1 (NS1)
of the Influenza virus contains a histone H3-like sequence that is able to bind to and
disrupt the activity of the human PAF1 transcription elongation complex (PAF1C). Loss
of PAF1C function leads to an impaired antiviral response and increased influenza viral
replication. Genome-wide binding analyses indicate that PAF1 is inducibly recruited to
anti-viral and inflammatory genes during infection, and that its presence coincides with

the recruitment of RNA polymerase II (Pol II) and the expression of target genes.
Altogether, our findings imply that exploiting histone mimicry could be a general
strategy for pathogens to subvert or co-opt host-processes for their own benefit. Our
studies also strongly suggest that proper regulation of transcription elongation by PAF1C
is an important rate-limiting step in the transcriptional response to pathogens.
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CHAPTER 1: INTRODUCTION
1.1

Selective Responses to Infectious Agents
The inflammatory response represents the first line of defense against invading

microorganisms. This response relies on the activities of a multitude of germline
encoded pattern recognition receptors (PRRs) that are able to detect specific pathogenderived macromolecules and components, commonly referred to as ‘pathogen-associated
molecular patterns (PAMPs) (Baccala et al., 2009; Kawai and Akira, 2007). Some PRRs
may also be involved in sensing damage-associated molecular patterns (DAMPs), which
are endogenous indicators of cellular damage (Matzinger, 1994; Seong and Matzinger,
2004).
Known PRRS include the Toll-like receptors (TLRs), retinoic acid-inducible gene I
(RIG-I)-like receptors, nucleotide oligomerization domain (NOD)-like receptors, as well
as C-type lectin receptors(Akira et al., 2006; Kawai and Akira, 2007). Upon recognition
of their cognate ligands, these receptors activate signaling cascades that lead to the
activation of various sequence-specific transcription factors, including nuclear factor
kappa-B (NF-κB) and the interferon regulatory factors (IRFs). Together, these
transcription factors coordinate the transcriptional response against pathogens. This
typically involves the expression of pro-inflammatory cytokines, such as interleukin-6
(IL-6), tumor necrosis factors-alpha (TNFα) or the type I interferons (IFNα/β). In turn,
these cytokines function to induce expression of anti-microbial genes and to recruit
effectors cells of the innate and adaptive immune system, all in all facilitating pathogen
clearance.
1

While the inflammatory response is critical for the clearance of pathogenic
intruders, inappropriate induction or prolongation of the inflammatory response may
result in damage to host tissues and threaten organism survival. As such, the cells have
evolved numerous strategies to control both the kinetics and magnitude of the
inflammatory response during infection. Aside from this, the cell must also develop
strategies to defend against antagonism by pathogen-derived effector molecules. I focus
here on regulation of the inflammatory response at the level of gene expression and the
chromatin-based mechanisms that controls it.

1.2

Overview of Chromatin Structure
The genomes of eukaryotic cells are maintained as a stable nucleoprotein-DNA

complex called chromatin. Chromatin is organized in a hierarchical manner, with the
nucleosome as its fundamental repeating subunit (Kornberg, 1974; Olins and Olins,
1974). Nucleosome bound tracts of DNA account for the first organizational level of
chromatin and appear by electron microscopy as “beads on a string” (where nucleosomes
are the “beads” and the intervening DNA is the “string”). Poly-nucleosome bound tracts
of DNA can then be further folded into higher ordered structures with increasing DNA
packing densities (Figure 1.1). Linker histones, which bear little structural resemblance to
the core histones, are believed to facilitate compaction by mediating inter-nucleosomal
interactions(Thomas, 1999; Vignali and Workman, 1998).

2

Figure 1.1: Overview of chromatin organization Genomes of eukaryotic cells are
organized into chromatin, which is composed of repeating units of nucleosomes.
Nucleosomes are connected to each other by short stretches of linker DNA, forming the
first organizational level of chromatin (“beads-on-a-string”). Nucleosome bound tracts of
DNA may fold in higher order structures to form condensed chromatin fibers. (Image
adapted from Tonna et al., 2010)
At the heart of chromatin, lies the nucleosome core particle. Each particle
comprises of approximately 147 base pairs of DNA wrapped in a 1.65 super helical turns
around an octamer of four ‘core’ histone proteins (H2A, H2B, H3 and H4)(Luger et al.,
1997). Octamers are formed from a central H3:H4 tetramer (formed from two H3:H4
dimers) that is flanked by two H2A: H2B dimers (Davey et al., 2002; Luger et al., 1997).
The histone proteins are relatively similar in structure, featuring a C-terminal “histonefold” domain as well as a short, unstructured N-terminal “tail” domain (Figure 1.2)
(Davey et al., 2002; Luger et al., 1997). The histone fold domains of the histone proteins
3

are responsible for mediating both histone-histone as well as histone-DNA interactions,
and form the bulk of the nucleosome core structure (Hacques et al., 1990; Luger et al.,
1997). On the other hand, the N-terminal tail domains of the histone proteins are thought
to extrude DNA bound nucleosome core particle. These exposed N-terminal “tail”
domains are also rich in basic residues, and are subject to a number of post-translational
modifications (See also section 1.4)
Packaging DNA into nucleosomes reduces DNA accessibility to cellular factors,
and thus has the potential to hinder cellular processes dependent on DNA (including
transcription (Huang and Bonner, 1962; Laybourn and Kadonaga, 1991; Morse, 1989;
Orphanides and Reinberg, 2000) , replication (Kelly et al., 2010) and DNA repair
(Fernandez-Capetillo et al., 2002)). Ability to regulate nucleosome structure, and
functionally couple chromatin states to cellular states is thus crucial for the eukaryotic
cell’s transcriptional response to the environment (including to infection). In the cell,
chromatin structure is directly controlled by the activities of two classes of regulators:
ATP-dependent chromatin-remodeling complexes and histone-modifying enzymes.
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Figure 1.2: Structure of the nucleosome core particle and the histone proteins. A.
Front (left panel) and side (right panel) views of the nucleosome core particle. The
nucleosome comprises of an octamer of the four core histone proteins, H2A (Yellow),
H2B (red), H3 (blue) and H4 (green). Octamers are formed from a central H3:H4
tetramer (formed from two H3:H4 dimers) that is flanked by two H2A: H2B dimers.
Approximately 147 base pairs of DNA are wrapped around the nucleosome in 1.65
helical turns. (Images adapted from Luger, 2003) B. Linear organization of the core
histones. The core histones are structurally similar to each other, comprising of a Cterminal histone-fold domain, as well as an N-terminal unstructured domain (‘tail’). Each
histone fold domain is made of 3 alpha helices (α1, α2 and α3), separated by
loops(L1,L2). In chromatin, the histone-fold domains form the bulk of the nucleosome
structure, whereas intrinsically disorder tail domains protrude out of the nucleosome.
(Images adapted from Dutnall and Ramakrishnan, 1997)
1.3

ATP-dependent chromatin remodeling complexes
Chromatin remodeling complexes are multi-subunit complexes that utilize ATP

hydrolysis to alter histone-DNA interactions. Some of these complexes may function to
5

bring about the exchange or eviction of nucleosomes, while others are required for
nucleosomal repositioning/sliding along the DNA (Mohrmann and Verrijzer, 2005).
Ultimately, these activities change the overall accessibility of nucleosome bound DNA
for processes like transcription and replication.
Chromatin remodeling complexes are divided into 4 families, based on their
ATPase subunit: SWI/SNF, ISWI, CHD/Mi-2 and Ino80 (Becker and Horz, 2002;
Eberharter and Becker, 2004; Mohrmann and Verrijzer, 2005). These complexes display
distinct remodeling activities, and may work to promote either activating or repressive
chromatin environments. For instance, the ATP-utilizing chromatin assembly and
remodeling factor (ACF) which is a member of the ISWI family, functions by generating
regularly spaced nucleosomes across the DNA, thus restricting DNA accessibility and
repressing DNA-dependent processes (Corona et al., 2002; Ito et al., 1999; ShogrenKnaak et al., 2006a). On the other hand, the SWI/SNF family of complexes has been
shown to create nucleosome free regions at the promoters and transcription start sites of
target genes, enhancing transcription factor binding and the recruitment of the
transcriptional machinery (Agalioti et al., 2000; Imbalzano et al., 1994; Ramirez-Carrozzi
et al., 2009).

1.4

Histone Modifications and Chromatin dynamics
Histone modifying enzymes constitute the second major class of chromatin

regulators. As mentioned previously, the core histone proteins are subject to multiple
post-translational modifications. The majority of the PTMs occur in the unstructured,
basic N-terminal tail domains. Histone modifications include lysine methylation,
6

acetylation, sumoylation and ubiquitination; arginine methylation; and serine and
threonine phosphorylation (Figure 1.3)(Kouzarides, 2007). These modifications are
largely regulated by two sets of enzymatic complexes: those that catalyze the addition of
a chemical group/protein to the histone tail substrate (“writers”) and those that catalyze
its removal (“erasers”). The activities of these enzyme complexes are typically sitespecific and many of them are found in conjunction with signaling molecules and larger
regulatory complexes.

Figure 1.3: Post-translational modification of the core histone proteins Important
histone modifications include phosphorylation (ph), acetylation (ac), methylation (me)
and ubiquitylation (ub1). Most of the known histone modifications occur on the Nterminal unstructured domains of the histone proteins, although those occurring in the
globular histone-fold domains (e.g. H3 at K56 and K79) have been reported to occur.
(Images adapted from Bhaumik et al., 2007)
Histone modifications may affect nucleosome and chromatin structure in three nonmutually exclusive ways. First, modifications may change the change nucleosome charge
density, and/or interfere with histone-DNA interactions. This could lead to the loss of
nucleosome stability or a change in nucleosome mobility. In support of this, force
7

spectroscopy studies report that hyper-acetylated nucleosomes are less stable than hypoacetylated nucleosomes (Brower-Toland et al., 2005).
Secondly, histone modification may impact inter-nucleosomal interactions and
inhibit the formation of higher order chromatin structures. Acetylation of lysine 16 in
histone H4 (H4K16), in particular, was found to prevent condensation of nucleosome
arrays into chromatin fibers in vitro (Shogren-Knaak et al., 2006b; Zhou et al., 2007) .
This could be in part explained by observations that residues 16 to 20 of the N-terminal
tail of histone H4 interacts with two acidic-patches in the histone-fold domain in histone
H2A of the adjacent nucleosome (Luger et al., 1997). H4K16 acetylation could function
either to neutralize electrostatic interactions (Shogren-Knaak and Peterson, 2006)
between H4 N-terminal tail and H2A, or to occlude H4 N-terminal tail-H2A interactions.
Finally, the presence of specific histone modifications along with their valency, can
be recognized or “read” by dedicated proteins through specialized protein domains
(Ruthenburg et al., 2007b; Taverna et al., 2007). Examples of such domains include
bromodomains that recognize histone acetyl-lysines; and PHD domains, Tudor domains
and chromodomains that bind to methylated lysines or arginines (Table 1.1). Importantly,
some reader proteins may also carry two or more of these domains, allowing them to
recognize multiple modifications simultaneously(Ruthenburg et al., 2007a). Thus, single
and combinatorial patterns of histones could have very different functional outcomes on
chromatin, depending on the proteins that recognize them. This forms the basis of the
‘histone code’ hypothesis (Strahl and Allis, 2000; Turner, 2000).
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Table 1.1: Recognition modules of known histone modifications. This table lists
examples of known chromatin associated “reader”- modules and the histone posttranslational modifications they are known to bind to. Examples of cellular proteins that
bear these domains are also indicated. (Adpated from (Taverna et al., 2007) and (Yun et
al., 2011) )
Reader Module

Known Proteins

Various

Rsc4, PB1, Brdt, Brd2, Brd3, Brd4

14-3-3

H3S10ph

14-3-3 proteins

BRCT

H2AXS139

MDC1

H3K4me0

BHC80, AIRE

H3K4me3

BPTF, TAF3, RAG2, PHF8

H3K9me3

SMCX

H3R2

WDR5

H3K4me1/2/3

CHD1

H3K9me2/3

HP1

H3K23me

MPP8

H3K27me2/3

PC, MPP8

H3K36me2/3

Eaf3, MSL3, MRG15

H3K4me

JMJD2A, JMJD2C

H3K9me2/3

TDRD7, UHRF1

H3K79me2

53BP1

H4K20

53BP1/Crb2, PHF20

H3R17

TDRD3

H4R3

TDRD3

H4K20me1/2

PHF20L1

PHD
WD40

Chromodomain
Royal
Family

Tudor

1.5

Position

Bromodomain

H3K4me1

PHF20L1

MBT

H3K9me1/2

SFMBT

Ankyrin Repeats

H3K9me2/3

G9a/GLP

Chromatin dynamics and the Inflammatory Response
As discussed before, chromatin structure imposes obstacles on transcription. As

such, chromatin structure and its dynamic regulation can play an important role in
determining transcriptional activation or repression of important inflammatory genes
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during homeostasis. A prime example of this would be chromatin-based regulation of the
IFNβ gene, which is an important cytokine induced in most somatic cell types upon viral
infection. Under steady state conditions, the IFNβ gene is kept repressed by the presence
of a nucleosome directly positioned at, and obscuring the TATA box at the promoter
(Lomvardas and Thanos, 2001). However, during stimulation, acetylation of histones H3
at lysine 9 and lysine 14 and H4 at lysine 8 within this nucleosome (Agalioti et al., 2002)
results in nucleosomal remodeling by the SWI/SNF complex and the recruitment of
TFIID to the promoter (Agalioti et al., 2000; Lomvardas and Thanos, 2001; Panne et al.,
2007; Parekh and Maniatis, 1999). These activities ultimately expose the DNA to the
cell’s transcriptional machinery, allowing for transcription of the gene to occur.
In addition to regulation during the activation phase, the chromatin environment
may serve to limit the overall activity of a given gene. Indeed, di-methylation of histone
H3 at lysine 9 (H3K9me2) within nucleosomes bound to the IFNβ promoter was shown
to correlate with its transcriptional output (Fang et al., 2012). Reduction of H3K9me2
abundance at the IFNβ promoter, through genetic ablation or pharmacological inhibition
of the G9a/GLP methyltransferase complex, correlated with an increased and more rapid
expression of IFNβ during gene activation. Levels of H3K9me2 at the IFNβ promoter
were thus suggested to be a determinant of cell-type specific differences in IFNβ
expression (Fang et al., 2012).
Beyond influencing transcription activation and repression, chromatin structure may
influence the activation kinetics of different subsets of genes during the inflammatory
response. Indeed, several groups have showed that the inducible recruitment of some
transcription factors to their target genes upon immune stimulation is highly dependent

10

on the pre-existing chromatin state on the target gene. For example, Saccani et al. showed
that NF-κB associates with its target genes with variable kinetics during LPS stimulation
of macrophages (Saccani et al., 2001, 2002). Certain genes were bound by NF-κB and
transcribed immediately upon NF-κB translocation to the nucleus (‘primary response
genes’), whereas others were bound and transcribed with significantly delayed kinetics
(‘secondary response genes’)(Saccani et al., 2001). This was attributed to the presence of
a nucleosome barrier at the secondary response genes, which could be overcome if the
cells were pre-treated/primed with IFNγ prior to LPS stimulation.
In support of this, a subsequent study showed that genes activated in LPSstimulated macrophages showed variable dependence on SWI/SNF chromatin remodeling
complex (Ramirez-Carrozzi et al., 2009; Ramirez-Carrozzi et al., 2006). In fact, the
majority of LPS-induced primary response genes in this study were activated in a
SWI/SNF independent manner, whereas SWI/SNF dependence was observed for the
secondary response genes (Ramirez-Carrozzi et al., 2009). Importantly, the differential
dependence on SWI/SNF activity correlated strongly with nuclease accessibility at the
promoters of target genes; Genes that were SWI/SNF dependent exhibited low nuclease
accessibility prior to LPS stimulation, suggesting that nucleosomal organization at the
gene was indeed important for determining the kinetics of gene activation (RamirezCarrozzi et al., 2006).

1.6

Pathogenic subversion/co-opting of host chromatin processes
Given the importance of chromatin dynamics and histone modifications in the

regulation of the immune response to pathogens, it is no wonder that many pathogens
11

have developed strategies that specifically target host chromatin processes. For instance,
the Shigella flexneri effector protein OspF migrates to the nucleus during infection,
where it specifically targets the ERK (extracellular signal regulated kinases) and p38
MAPKs (mitogen-activated protein kinases) for de-phosphorylation (Arbibe et al., 2007).
This inhibits MAPK mediated histone H3 serine 10 phosphorylation, resulting in
inhibited transcriptional activation of the inflammatory genes and to the benefit of the
bacteria(Arbibe et al., 2007).
Chromatin dynamics has also been shown to play a major role in the life cycles of
many viruses. In particular, DNA viruses, which replicate in the nucleus, must contend
with the host-mediated chromatinization of their genomes during infection. Several DNA
and RNA viruses thus evolved mechanisms that co-opt several host chromatin processes
to regulate viral gene expression. For instance, during herpes simplex virus (HSV)
infection, viral VP16 protein is required to recruit histone acetyltransferases and
chromatin remodeling complexes to the chromatinized viral genome, allowing for the
activation of viral genes (Herrera and Triezenberg, 2004). In the absence of VP16,
nucleosomes assembled on the viral genome restrict DNA accessibility and repress the
viral gene transcription (Herrera and Triezenberg, 2004).
Viruses that integrate into the genome, such as the retroviruses have also evolved
strategies to use host chromatin processes for their benefit. For one, heterochromatic
silencing of integrated human immunodeficiency virus (HIV) has been suggested to
facilitate maintenance latent reservoirs of virally infected cells in the host and evade
immune clearance (Pierson et al., 2000). In fact, reactivation of HIV from latency
involves chromatin remodeling and the generation of open chromatin at the integrated
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viral genome. This is mediated by the HIV protein Trans-activator of transcription, TAT,
which recruits histone acetyltransferases (HATs), including CBP/p300 and p/CAF (Deng
et al., 2000; Deng et al., 2001; Kiernan et al., 1999), to the viral promoter.
Hyperacetylation of nucleosomes by HATs at the viral promoter facilitates chromatin
remodeling, and the formation of a permissive chromatin environment for transcription
(Lusic et al., 2003). Finally, TAT also recruits the positive transcription elongation
factor-b (PTEF-b), which phosphorylates the C-terminal domain of Pol II to promote
transcription elongation through the viral genome (Yang et al., 2005).

1.7

Beyond the histone code: Other means to subvert host chromatin processes
The specialized effector domain present in ‘readers’ recognize short amino acid

sequences. Structural studies have also proven that the modularity of this recognition can
be artificially modified and that histone tail modifications do not necessarily have to be
recognized in the context of the entire histone tail (Li et al., 2007). Rather, the histone
tails could be envisioned as being composed of multiple overlapping short linear motifs,
with each motif (and its modification state) functioning as a discrete unit of information
for histone- and chromatin-bound proteins (Fischle et al., 2003).
An interesting implication of this hypothesis is that non-histone proteins that bear
similar motifs might be subject to the same regulation and protein-protein interactions
afforded to the histones. This raises an interesting consideration related to host-pathogen
interactions: Can pathogens take advantage of the histone code by supplementing their
own proteome with histone-derived motifs?
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Several histone-like sequences in non-histone proteins have already been well
characterized in the recent years. One of these proteins is the methyltransferase G9a,
which is responsible for histone H3 di-methylation at lysine 9. G9a bears a 163-ARKT166 motif that strongly resembles the 7-ARKS-10 motif of its target H3 target residue
(Figure 1.4A). Consistent with this, G9a was found to auto-methylate itself on lysine 165
(Chin et al., 2007; Sampath et al., 2007), and this methylation was required for G9a to
form a co-repressor complex with a separate H3K9me2 reader and chromodomaincontaining protein, HP1γ (Sampath et al., 2007).
In addition to this, the H3-like sequence in G9a is also conserved in its homologue
and hetero-dimerization partner GLP (Tachibana et al., 2005) (Figure 1.4A), even though
the two proteins share relatively poor primary sequence conservation in their N-terminal
domains. Like G9a, the H3-like sequence of GLP is subject to auto-methylation. GLP
methylation is thought to create a binding site for another chromodomain containing
protein M phase phosphoprotein 8, MPP8 (Chang et al., 2011). Interestingly, the
chromodomain of MPP8 also interacts with methylated DNMT3A (a de novo DNA
methyltransferase), which turns out to also carry a similar histone H3K9-like sequence
that is recognized and methylated by the G9a/GLP complex (Figure 1.4A). MPP8 dimers
binding both methylated G9a/GLP complex and methylated DNMT3A were thus
proposed to functionally link two transcriptionally repressive events (i.e. H3K9
methylation and DNA methylation activities) to the same complex (Figure 1.4B) (Chang
et al., 2011).
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Figure 1.4: Histone mimicry in G9a, GLP and DNMT3a proteins. A. Domain
architecture and aligned sequences for mouse (m) or human (h) G9a, GLP and Dnmt3a
proteins against histone H3. B. Model for GLP/G9a complex interactions with Dnmt3a
through MPP8 protein. MPP8 homo-dimers bind to automethylated G9a/GLP complex
and methylated Dnmt3a protein. This could potentially couple G9a/GLP mediated H3K9
di-methylation with Dnmt3a mediated de novo DNA methylation. ANK: Ankyrin repeats,
SET: Su(var)3-9, E(z) Trithorax domain; DNA Mtase: DNA methyltransferase; PWWP:
PWWP protein interaction domain. (Images adapted from Sampath et al., 2007; Badeaux
and Shi, 2013)

1.8

Motif mimicry is prevalent amongst pathogens
Motif mimicry is a common tactic used by pathogens to subvert or co-opt host cell

processes (Davey et al., 2011)(see also Table 1.2). In fact, the putative histone-derived
motifs are highly reminiscent of a class of compact, non-globular protein interaction
interfaces known as short linear motifs (SLiMs) (Davey et al., 2012; Diella et al., 2008;
Van Roey et al., 2013). SLiMS are found widely throughout the genome, and serve many
regulatory functions, such as directing ligand binding, serving as sites for posttranslational modification and mediating complex assembly. Like the histone –tail motifs,
multiple SLiMs can overlap each other, or be used in a cooperative fashion. The ability of
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some SLiMs to be post-translationally modified also allows them to alternate between
different functional states that can impact downstream protein-protein interactions
(Davey et al., 2012; Diella et al., 2008; Van Roey et al., 2013). Thus, the prevalence of
these motifs in the regulation of cell function, coupled with their intrinsic properties, has
made them ideal targets for pathogens(Davey et al., 2011).
Perhaps, the most well described example of motif mimicry in pathogens would be
within the adenovirus E1A protein(Pelka et al., 2008). The E1A protein contains a
collection of independent protein binding motifs that allow it to interact with a diverse
array of host proteins. These include host CtBP (co-repressor C-terminal binding protein)
through a short PxDLS motif (where x is any amino acid) (Boyd et al., 1993; Schaeper et
al., 1995); cell cycle regulator pRb through a LxCxE motif(Carvalho et al., 1995); BS69
co-repressor through a PxLxP motifs(Ansieau and Leutz, 2002); and CBP/p300 through a
FxD/ExxxL motif (O'Connor et al., 1999). E1A mediated interactions with these proteins
allow the virus to target cell cycle- and growth related gene expression, thus enhancing
viral replication. Further examples of viral mimicry of host derived motifs and their
functional outcomes are displayed in Table 1.2.
Bacteria pathogens have also been shown to mimic host short motifs, although these
do not seem to occur to the extent as in viruses, which are obligate intracellular parasites.
For instance, the Vibrio cholera heat labile toxin (Cholera toxin, CT) contains a Cterminal ER rentention signal KDEL (Sixma et al., 1991). Upon entry into the ER, ERresident chaperones and enzymes facilitate toxin activation (Tsai et al., 2001). The
activated toxin is then able to enhance activation of cellular adenyl cyclase, resulting in a
cascade of events that lead to an increased excretion of chloride ions and water from the
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affected cells (Sharp and Hynie, 1971). Production of CT is thought to facilitate host
colonization, and may also be a mechanism for the bacterium to generate cAMP (via
cellular adenyl cyclase) as an energy source.
Interestingly, some viruses have developed effector proteins that hijack the
functions of cellular motifs. An example of this occurs in the Papillomaviruses (PV). The
PV targets several cellular proteins, including E6AP, interferon regulatory factor-3
(IRF3), the notch co-activator MAMLI, all of which contain acidic leucine (L)-rich
sequences comprising an LxxLL motif(Zanier et al., 2013). These interactions are
mediated by a unique fold within the PV E6 oncoprotein, and are essential for the virus to
suppress the host immune response and induce oncogenesis (Zanier et al., 2013). Loss of
the LxxLL binding site in the E6 protein results in the loss of transformation and
degradation activities of the E6 protein (Zanier et al., 2013). Altogether, these studies
highlight the important role of motif biology in the cell, and why they represent attractive
targets for pathogens to manipulate.
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Table 1.2: Examples of pathogen mimicy of host-derived short motifs
Motifs are presented in single letter amino acid code; X refers to any amino acid.‡ E1A
Conserved region 1; †E1A conserved region 3; $: Protein C-terminus. Amino acids
indicated within square braces can be substituted for each other at that position. Adapted
from Davey et al., 2011
Host Target

Viral
Protein

Virus

Motif

Outcome

Ref.

AP-1

Nef

HIV

ExxxLL

CD4 downregulation; enhanced viral
infectivity

Craig et al.,
1998

Calcineurin

p12

HTLV1

SPxLxLT

Inhibition of NFAT-calcineurin
interactions; Transcriptional repression

Kim et al.,
2003

CtBP

E1A
(CR1)‡

Adenovirus

PxDLS

Loss of CTBP1 acitivity; Enhanced
transformation of cells

Schaeper et
al., 1995

CtBP

E1A
(CR3)†

Adenovirus

RxxTG

Loss of CTBP1 acitivity; Enhanced
transformation of cells

Bruton et al.,
2008

Farnesyltransferase

HDAg-L

HDV

Cxxx$

HADg-L Farnesylation; Required for viral
biogenesis

Glenn et al.,
1992

HCF

VP16

HSV

EHxY

Activation of viral immediate early genes;
HCF-1/OCT-1/VP16 complex formation

Lu et al., 1998

JAK

LMP1

EBV

PxxPxP

Activation of NF-KB signaling; Repression
of host apoptotic pathways

Gires et al.,
1999

NEDD4

VP40

Ebola

PPxY

Ubiquitylation of VP40; Role in viral
budding

Harty et al.,
2000

Oligosaccharyltransferase

E1

HCV

Nx[ST]

Glycosylation of E1; Role in protein folding
and viral entry

Meunier et al.,
1999

p300/CBP

E1A

Adenovirus

FxDxxxL

Enhanced expression of viral genes

Ferreon et al.,
2009

PDZ domain(s)

E6

HPV

x[ST]xV$

Targetted degradation of host tumor
suppressors MAGI-I and SAP97/Dlg

Zhang et al.,
2007

PDZ domain(s)

NS1

Influenza A
virus

x[ST]xV$

Interactions with host PDZ domainscontaining proteins

Obenauer et
al., 2006

RB

E1A

Adenovirus

LxxLYD

Displacement of E2F proteins from Rb

SIAH1

ORF45

KSHV

PxAxV

Degradation of ORF45; Putative role in
viral re-activation

Liu and
Marmorstein,
2007
Abada et al.,
2008

TR

E1A

Adenovirus

LxxLIxxxL

Dysregulation of thyroid hormone receptor
function

Meng et al.,
2005

TRADD

LMP1

EBV

YYD$

Activation of NF-KB signaling; Repression
of host apoptotic pathways

Izumi and
Kieff, 1997

TRAF2

LMP1

EBV

PxQxT

Activation of NF-KB signaling; Repression
of host apoptotic pathways

Ye et al., 1999

Tsg101

Gag

HIV

PTAP

Recruitment of Tsg101 to endosome; Role
in viral budding

Pornillos et
al., 2002

18

1.9

Why Histone mimicry?
There are several reasons as to why histone motif mimicry might be a particularly

successful strategy for pathogens:
Evolutionary plasticity
For one, these motifs are short, with the capacity to encode a functional interaction
interface within three to ten amino acids (four in the case of G9a, GLP and DNMT3A
(Chang et al., 2011; Chin et al., 2007; Sampath et al., 2007)). Generation of a functional
motif de novo in unrelated protein is thus not likely to require more than a few mutations.
In addition, the short sequence length also allows pathogens to utilize multiple motifs at
any one time. For pathogens, this is an especially important consideration, given that their
evolutionary space is constrained by their small genomes.
Modular functionality.
Secondly, as part of the histone protein, these motifs play especially important roles
in regulating chromatin structure and gene expression. Incorporation of individual and/or
combinations of such histone motifs into a pathogen-derived protein could be sufficient
for the pathogen to gain control over entire chromatin regulatory pathways in the cell.
Specifically, pathogens could use such motifs to inhibit host chromatin processes, or use
these motifs to co-opt cellular machinery.
Support for this has emerged from studies involving inhibitors (I-BET and JQ1) of a
class of chromatin reader proteins known as the BET proteins. The BET proteins are a
family of bromodomain containing proteins that bind to acetylated histones (particularly
to histone H4) (Filippakopoulos et al., 2012). The BET inhibitors function as structural
‘mimics’ of acetylated histone H4 tails and exert their effects by competing with histone
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binding to the BET bromodomains (Filippakopoulos et al., 2010; Nicodeme et al., 2010).
Treatment of cells with either I-BET or JQ1 was sufficient to block BET recruitment to
and function on chromatin (Dawson et al., 2011; Filippakopoulos et al., 2010; Nicodeme
et al., 2010). Indeed, inhibition of BET proteins by I-BET resulted in the repression of the
transcriptional response to LPS stimulation in macrophages (Nicodeme et al., 2010).
Mimicry is difficult to counter.
Third, mimicry, in itself, is a particular successful survival strategy for pathogens
against their host. Typically, pathogen-host interactions can be exemplified by a simple
arms race where host adaptation to virus is counteracted by pathogen adaptation, and vice
versa (Daugherty and Malik, 2012). In the case of mimicry however, the spectrum of
potentially useful adaptations that would facilitate host escape from mimicry are limited
by the need to maintain other host–host interactions and functions(Elde and Malik, 2009).
In addition, host defenses against pathogenic mimicry are further confounded by the fact
that the host must now be able to not only recognize the offending pathogen-derived
molecule, but must similarly be able to tell it apart from itself (Elde and Malik, 2009).
This is especially so in the case of the histone proteins. Given the vast number of
interactions the histone tail motifs coordinate on chromatin and the crosstalk in which
they engage in, histone tail mutations are not well tolerated. Indeed, it was recently
shown that expression of histone H3 bearing missense mutations (lysine 27 to
methionine, K27M) was sufficient to cause the loss of tri-methylated H3K27 throughout
the cell, even in the presence of wild-type histone H3 protein (Lewis et al., 2013). While
these observations do not preclude the possibility of compensatory mutations occurring in
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histones during a host-pathogen arms race, the overall probability of that occurring is not
likely to be high.

1.10 Hypothesis
Based on the above observations, we propose that mimicry of histone-derived
motifs is likely to be a viable strategy by which pathogens can dysregulate host cell
chromatin state and gene expression during infection. Specifically, pathogen histone
mimics could exert their effects on host gene expression either by inhibiting the binding
cellular factors from chromatin. Alternatively, pathogens might use mimicry to gain
access to and co-opt the host chromatin processes. Understanding how pathogens can
exploit the histone code will give insight into cellular processes, and may also be
instrumental in developing therapeutics.
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CHAPTER 2: MATERIALS AND METHODS
2.1

Cells and viruses
A549 and Madin–Darby canine kidney (MDCK) cells were obtained from the

American Type Culture Collection (ATCC) and were maintained in Dulbecco’s minimal
essential medium (DMEM) (Gibco, Invitrogen) supplemented with 2mM Glutamine
(Gibco, Invitrogen), 10% Fetal Bovine Serum (Hyclone) and penicillin-streptomycin
(Gibco, Invitrogen). The A/Wyoming/3/2003 (H3N2), A/Puerto Rico/8/1934 (H1N1)
viruses and the Flag-NS1 strains were propagated on MDCK cells. The A/Puerto
Rico/8/1934(ΔNS1) (PR8/ΔNS1) virus was propagated in NS1-expressing MDCK cells.
Vesicular stomatitis virus (VSV) (Indiana strain) was propagated in BHK cells.

2.2

Virus infections
A549 cells were plated at 5 x 105 cells per well in a 6-well plate 16-18 hours prior

to infection. For infections, A549 cell monolayers were washed once in PBS, before
being inoculated with 200 ul of influenza virus diluted to the appropriate MOI in
PBS/0.3% BSA. Virus was allowed to adsorb onto the monolayer for 1 hour at 37°C, and
plates were rocked gently every 10-15 minutes to ensure that the cell monolayer did not
dry out. After viral incubation, the remaining virus was aspirated, and 2 ml of fresh
growth medium was added back to the wells. Cells were then collected at various times
post-infection for further assays.
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2.3

Virus Growth Curves and Plaque Assays
Confluent A549 cells were infected at a multiplicity of infection (MOI) of 0.01.

Following infection, cells were maintained in DMEM containing 0.3% Bovine Serum
Albumin (BSA) and 0.375 μg/ml of tosylsulfonyl phenylalanyl chloromethyl ketone
(TPCK)-treated trypsin (Sigma). At the indicated time post infection, cell culture
supernatants were collected. Viral titers at each time point were then quantified by plaque
assays on MDCK cells.
For quantification of virus, dilutions of viral stocks or culture supernatants of the
infected cells were adsorbed for 1 hour at room temperature onto layers of confluent
MDCK cells. The infected MDCK cells were then overlaid with a 2 ml solution of
DMEM containing 0.3% BSA, 25mM HEPES buffer (Gibco, Invitrogen), 2mM
Glutamine (Gibco, Invitrogen), penicillin-streptomycin (Gibco, Invitrogen), 1 μg/mL
TPCK-trypsin and 1% agar (LP0028, Oxoid). Plates were then incubated 48 to 72 hours
until plaques could be observed. Plaques were then fixed in a solution of 7%
formaldehyde, before being visualized by crystal violet staining.

2.4

Generation of Flag-NS1 viruses
The NS1 and NEP open-reading frames (ORFs) on the Influenza NS segment share

a common N-terminal sequence. As such, to attach the Flag tag specifically to NS1
without disrupting the NEP ORF, the NS segment was modified as follows. The first 90
nucleotides of the 3’vRNA, with all the ATG start codons deleted, served as the 3’ vRNA
packaging signal. The endogenous splice donor site for NEP was left unchanged. The
3’vRNA packaging signal was followed by the 3XFlag sequence
23

(MDYKDHDGDYKDHDIDYKDDDDK) and the NS1 ORF with stop codon. Two silent
mutations in the endogenous splice acceptor site in the NS1 ORF (TTCCAGGACATA)
were introduced to prevent splicing at this site (TTCCCGGGCATA) as described
previously (Varble et al., 2010). The Flag-NS1 ORF was followed by a new splice
acceptor site that corresponds to the 459-527 nucleotides of the wild type NS segment,
and the entire NEP-ORF with ATG. In this design, the 3XFlag-NS1 and NEP are
generated from the unspliced or spliced mRNAs, accordingly. The deletion of the hPAF1
binding sequence was generated by introducing a stop codon after amino-acid 220 of the
NS1 coding sequence. The modified NS segments were generated using fusion PCR and
cloned into a pDZ vector using SapI restriction sites(Quinlivan et al., 2005). Flag-NS1
viruses were generated using reverse genetics system (Fodor et al., 1999). The sequence
of the NS segment in the Flag-NS1 viruses were confirmed by RT-PCR and sequencing.
Titers of viral stocks were determined by plaque assay in MDCK cells. A schematic of
the targeting strategy is shown in Figure 2.1.
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Figure 2.1: Generation of Flag-tagged NS1 virus Schematic of the genomic structure
of the NS segment of wild-type Influenza A virus (wt) and the strategy used for the
generation of the Flag-NS1 expressing influenza viruses. Mutation of the splice acceptor
site of the NS segment enables selective Flag-tagging of NS1. SD, SA splice donor or
acceptor sites, respectively.

2.5

siRNA mediated Knockdowns
Cells were transfected using Lipofectamine™ RNAiMAX Transfection Reagent

(Invitrogen) according to the manufacturer’s instructions. Cells were transfected with
siRNA pools targeted to either human PAF1 (L-020349-01, Dharmacon), CHD1 (L008529-00, Dharmacon) or a control non-targeting pool (D-001810-10-05, Dharmacon)
at a final siRNA concentration of 50 nM. Transfected cells were used for further assays at
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48 hours post transfection and gene knockdown efficiency was determined by
quantitative PCR and/or Western blotting.

The sequences for the pooled human CHD1 siRNA oligonucleotides are as follows:
CACAAGAGCUGGAGGUCUA
GAUGAAGAUUGGCAAAUGU
CGAUCUCAUUUCUGAAUUA
GUACCGCUCUCCACUCUUA

The sequences for the pooled human PAF1 siRNA oligonucleotides are as follows:
GUGCCAUGGAUGCGAAAGA
GAGUACAACUGGAACGUGA
CUGUAGAAGAGACGUUGAA
CCACUGAGUUCAACCGUUA

2.6

Preparation of RNA-sequencing (RNA-Seq) libraries
RNA-Seq libraries were prepared with a protocol adapted from reference

Rosenberg et al., 2011. Briefly, total RNA was extracted from infected A549 cells at
different time points post infection using Trizol reagent (Invitrogen). Ribosomal RNA
was depleted using the RiboMinus™ Eukaryote Kit for RNA-Seq (Invitrogen). Prior to
fractionation, RNA was also treated with RNase-free DNase I (Qiagen) and purified
using the RNeasy MinElute kit (Qiagen).
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The RNA was fractionated in fragmentation buffer (40mM Tris acetate, pH8.2,
100mM potassium acetate and 30mM magnesium acetate) at 94 °C for 4.5 min. The
fragmented RNA was reverse transcribed (Superscript III, Invitrogen) and then purified
using the QIAGEN QIAquick PCR purification kit. The complementary DNA (cDNA)
was then end-repaired using T4 DNA polymerase (NEB), DNA polymerase I, Large
(Klenow) Fragment (NEB) and T4 PNK (NEB). End-repaired DNA was purified using
the QIAGEN Qiaquick PCR purification kit. Klenow Fragment (NEB) was used to add
‘A’ bases to the 3’end of the DNA fragments before being purified by the QIAGEN
MinElute PCR purification kit. Sequencing adaptor oligonucleotides (Illumina) were
added with T4 DNA Ligase (NEB). Double-stranded cDNA libraries were then separated
by electrophoresis through a 2% agarose gel, and fragments ranging from approximately
175 nt to 225 nt were excised and amplified by PCR with linker-specific primers
(Illumina). The integrity and quality of RNA and cDNA were monitored throughout on
the Agilent Bioanalyzer 2100. Ultra-high-throughput sequencing was performed on the
Illumina Genome Analyzer II (GAII) by standard sequencing-by-synthesis reaction for
36-nt reads.

2.7

Immunofluorescence
A549 cells were cultured on coverslips overnight and then infected with the virus

strains specified. At the indicated interval post-infection, cells were fixed in 3%
paraformaldehyde (EMS) for 10 min at room temperature. Coverslips were washed in 1x
PBS and blocked with blocking solution (1mg/ml BSA, 3% FBS, 0.1% Triton X100 and
1mM EDTA pH 8.0 in PBS) for 30 min at room temperature. Cells were then probed
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with mouse monoclonal antibody against NS1 (diluted 1:300), or mouse monoclonal antiFlag antibody (diluted 1:300) for 1 hr and detected by Alexa 594 conjugated Goat antimouse antibodies (Invitrogen). DNA was counterstained with DAPI.

2.8

Gene Expression Analysis by Microarray
Cells were infected with a virus strain that lacks NS1 (PR8/∆NS1) at MOI 1 or

stimulated with recombinant human IFN beta 1a (IFNβ1) (11415-1, PBL Interferon
Source). Where cells were stimulated with IFNβ1, a concentration of 500 units/mL of
cytokine was used. For infections with wild-type H1N1 influenza virus, the A/Puerto
Rico/8/1934 (H1N1) strain was used at MOI 3. Infections with vesicular stomatitis virus
(Indiana strain) were done at MOI 3. For Poly(I:C) stimulations, cells were transfected
with Poly(I:C) at a final concentration of 2 µg/ml using the Lipofectamine2000 reagent
(Invitrogen). Total RNA was isolated from infected, IFNβ1 stimulated or Poly(I:C)
stimulated siRNA treated A549 cells using the RNeasy Kit (QIAGEN). 200ng of total
RNA per sample was used to prepare biotin-labeled RNA using MessageAmp™ Premier
RNA Amplification Kit (Applied Biosystems) and hybridized to HumanHT-12 v4
Expression BeadChips (Illumina). Data analysis was performed using the GeneSpring
GX11.0 software (Agilent Technologies). Raw expression values were subjected to
quantile normalization, and baseline transformation was performed to either the median
of control samples for fold change analyses (see below), or to the median of all samples
for comparisons between unstimulated siRNA treated cells.
To compare gene expression in siPAF- and control siRNA-treated cells, the
normalized signal intensities of each microarray probe in the stimulated (infected or
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IFNβ1 stimulated) samples was paired with and subject to baseline transformation against
that of the corresponding un-stimulated sample that had been subject to the same siRNA
treatment. An analysis of variance test (ANOVA) (p < 0.001), followed by a post hoc
(TUKEY HSD) test and the indicated fold change cut offs were applied to identify probesets that showed statistically significant differences in expression upon stimulation for
each siRNA treatment. Stimulation induced genes were defined as genes that are induced
≥2 fold (p <0.001) in virus infected cells compared to un-stimulated cells in at least one
siRNA treatment. hPAF1 dependent genes in virally infected and Poly(I:C) stimulated
cells were defined as genes in which siPAF treatment induced a lower or greater (≥ 2
fold, p <0.001) magnitude of response compared to siCtrl treated cells upon stimulation.
hPAF1-dependent genes in IFNβ1-stimulated cells were defined as genes in which siPAF
treatment induced a lower or greater (≥ 1.5 fold, p <0.001) magnitude of response
compared to siCtrl-treated cells upon stimulation. All p-value computations were
subjected to multiple testing correction using the Benjamini Hochberg method.
For microarray analyses on the kinetic experiments with siPAF1 treated cells, the
cells were infected with PR8/∆NS1 at MOI 3. Total RNA was isolated used for
microarray as described before. For the analysis, raw expression values were subjected to
quantile normalization, and baseline transformation was performed to the median of all
samples. Samples were compared via T-tests, since we did not include non-siRNA treated
cells in these experiments. Entities that displayed > 2 fold change in expression (p<0.01)
were subjected to further analyses.
Hierarchical clustering (Eisen et al., 1998) of data was performed and visualized
using the Cluster and Treeview software (http://www.eisenlab.org/eisen/). Genes that are
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represented by multiple probesets on the microarray are depicted by the average of those
probesets in the heatmaps generated.
Functional analyses were conducted through the use of Ingenuity Pathways
Analysis (Ingenuity® Systems, www.ingenuity.com). The Functional Analysis identified
the biological functions that were most significant to gene lists generated from the
microarray. Right-tailed Fisher’s exact test was used to calculate a p-value determining
the probability that each biological function assigned to that data set is due to chance
alone.

2.9

Quantitative Real-Time PCR (qPCR)
Total RNA from stimulated cells was extracted using the RNeasy kit (QIAGEN)

according to the manufacturer’s instructions. RNA was DNase treated using the RNase
free DNase kit (QIAGEN) and cDNA was synthesized using the First strand cDNA
synthesis kit (Roche). qPCR was performed using SYBR green (Roche) or the
LightCycler 480 Probes Master mix (Roche). The sequences of primers used are shown
in Table 2.1.
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Table 2.1: List of Primers used in this study. Listed are primers that have been used in
this study. Hs: Homo sapiens; F: Forward primer; R: Reverse primer
Target
NP mRNA
(H3N2/Wyoming/2003)
NS1 mRNA
(H3N2/Wyoming/2003)
PB2 mRNA
(H1N1/PR/8/34)
NP mRNA
(H1N1/PR/8/34)
M1 mRNA
(H1N1/PR/8/34)
M1 mRNA
(H1N1/PR/8/34)
Universal primer
(Influenza A)

Primer name
H3N2_NP F
H3N2_NP R
H3N2_NS1 F
H3N2_NS1 R
PR8_PB2 F
PR8_PB2 R
PR8_NP F
PR8_NP R
PR8_M1 F
PR8_M1 R
PR8_M2 F
PR8_M2 R

Uni-12
hs_HPRT1 F
Hs HPRT1
hs_HPRT1 R
hs_PAF1 F
Hs PAF1
hs_PAF1 R
hs_IFNB1 F
Hs IFNB1
hs_IFNB1 R
hs_CCL5 F
Hs CCL5
hs_CCL5 R
hs_IFIT1 F
Hs IFIT1
hs_IFIT1 R
hs_IFIT2 F
Hs IFIT2
hs_IFIT2 R
hs_OAS1 F
Hs OAS1
hs_OAS1 R
hs_ISG15 F
Hs ISG15
hs_ISG15 R
hs_MX1 F
Hs MX1
hs_MX1 R
hs_IFIT1_prom F
Hs IFIT1 promoter/TSS
hs_IFIT1_prom R
hs_IFIT1_TES F
Hs IFIT1 TES
hs_IFIT2_TES R
hs_IFI6_prom F
Hs IFIT2 promoter/TSS
hs_IFI6_prom R
hs_IFI6_TES F
Hs IFIT2 TES
hs_IFI6_TES R

Sequence
CCCAGGAAATGCTGAGATCG
GTCGTACCCACTGGATACTG
TGGAAGGACCTCTTTGCATCA
TCTTCGGTGAAAGCCCTTAGT
AGAGACGAACAGTCGATTGCCG
ATCGCTGATTCGCCCTATTGAC
TATTGAGAGGGTCGGTTGCTCACA
ACCAGTTGACTCTTGTGTGCTGGA
GTGGCATTTGGCCTGGTA
ATAGCCTTAGCTGTAGTGCTGG
TAACCGAGGTCGAAACGCCTA
GCCCTCCTTTCAGTCCGTATTT
AGCAAAAGCAGG

Use
mRNA detection
mRNA detection
mRNA detection
mRNA detection
mRNA detection
mRNA detection
Reverse
Transcription

TGAGGATTTGGAAAGGGTGT
mRNA detection
ACAGTCATAGGAATGGATCT
CAATTCCCACCGGACTCTG
mRNA detection
GTTTGTGCTGTTTCTCCAAGG
CAGTCTGCACCTGAAAAGATATTATG
mRNA detection
GATTTCCACTCTGACTATGGTCCAGG
AAGCTCCTCTGAGGGGTTGA
mRNA detection
TTGCCAGGGCTCTGTGACCA
TCCAGGGCTTCATTCATAT
mRNA detection
TTCGGAGAAAGGCATTAGA
AGGCTTTGCATGTCTTGG
mRNA detection
GAGTCTTCATCTGCTTGTTGC
GATCTCAGAAATACCCCAGCCA
mRNA detection
AGCTACCTCGGAAGCACCTT
ACTCATCTTTGCCAGTACAGG
mRNA detection
CAGCTCTGACACCGACATG
GTTTCCGAAGTGGACATCGCA
mRNA detection
GAAGGGCAAGTCCTGACACT
CAGCTTACACCATTGGCTGCTGTT
ChIP validation
GGTTGCTGTAAATTAGGCAGCCGT
TTGGCTGACTTCACCTAGCTCACT
ChIP validation
CAAAGGACATAGAGGCACCCTGT
TGATGCCCACACTTCATAGCTCCT
ChIP validation
TTTACTCGCTGCTGTGCCCATC
TGCTTGGGTTGTCTTCTCCTTCCT
ChIP validation
AAGAAGCGCTAGTGATCACCCTCA

Commercially Available Primers
Targets
Hs HPRT1
Hs ISG15
Hs IFNB1
Hs DDX58
Hs CHD1
Hs PAF1

Company
Applied Biosystems
Applied Biosystems
Applied Biosystems
Applied Biosystems
Applied Biosystems
Invitrogen

Catalog Number
4333768F
Hs00192713_m1
Hs02621180_s1
Hs00204833_m1
Hs00154405_m1
4331182
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Format
Taqman Probe
Taqman Probe
Taqman Probe
Taqman Probe
Taqman Probe
Taqman Probe

2.10 In vitro methylation assay
Methylation assays were performed as previously described (Nishioka et al.,
2002)with minor variations. In brief, 300 ng of protein or peptide substrate and 100 ng of
histone methyltransferases (HMT) were incubated with [3H] SAM in HMT buffer (50
mM Tris-HCl (pH 8.5), 5 mM MgCl 2 , 2 mM DTT) for 30 minutes at 37⁰C. The reaction
was then immunoprecipitated for 1 hour with avidin beads (used with peptide substrates)
or GST beads (used with GST-tagged substrates) and then washed extensively in BC150.
This step minimizes non-specific radioactive incorporation. Eluted material was then
subjected to PAGE, gel drying and exposed for radioactive signal detection. Set7/9 was a
gift from Dr. Marc-Werner Dobenecker and purified SET1C was a gift from Dr. Tang
Zhanyun.
2.11 In vitro acetylation assay
HAT reactions were performed in HAT assay buffer (50 mM Tris at pH 8.0, 10%
glycerol, 50 mM KCl, 0.1 mM EDTA, 10 mM butyric acid, 1 mM dithiothreitol [DTT], 1
mM phenylmethylsulfonyl fluoride [PMSF]). Protein or peptide substrates (100ng) were
incubated with [3H]acetyl coenzyme A (CoA) and purified TIP60 (Gift from Dr. XiaoJian Sun) for 1h and affinity purified using analogous immunoprecipitation of the
substrate before PAGE and detection on autoradiography film (see in vitro methylation
assay).
2.12 Immunoprecipitation
Nuclear extracts from untreated and infected cells (pretreated with HDAC inhibitors
when required) were denatured in Laemmli buffer (63mM Tris HCl, 10% Glycerol, 2%
SDS, pH6.8) at 95⁰C for 10 minutes (with cycles of vortexing). The extract was then
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diluted to a final concentration of 0.2%SDS in BC150 and sonicated with a Bioruptor
(Diagenode). Proteins were then immunoprecipitated with Flag M2 antibody (Sigma)coupled magnetic beads for 2 hours at 4⁰C. After extensive washing in BC300 and
BC150 (last wash), the material was eluted with Flag-competing peptide at 37⁰C for 15
minutes (3 cycles) and the eluted material was combined and acetone-precipitated.
Western blotting for NS1 modifications was followed by stripping and re-probing for
loading control.

2.13 Peptide pull-down assays
Pull-down assays with extracts and recombinant proteins were performed as
described previously(Wysocka, 2006). Nuclear extracts were prepared from HEK293
cells using the Dignam protocol (Dignam et al., 1983). 108 cells were used per pull-down
assay. Salt and Triton-X100 concentrations were 250mM and 0.2% (v/v), respectively.
Fractions from nuclear extracts fractionated on Heparin column, were pre-cleared with
avidin beads and then incubated with biotinylated-peptide pre-bound to avidin beads for
3h at 4°C. Approximately 2µg of peptide was used per pull down. Beads were washed
eight times with BC300 containing protease inhibitor cocktail (Roche). Bound proteins
were eluted from the resin using 100mM glycine, pH2.8 and run on Micro-Spin Columns
(Pierce, 89879). Eluates were combined, neutralized, and analyzed by SDS–PAGE. A
similar procedure was used for peptide pull down using purified protein (100ng) or
reconstituted complex (1µg). All peptides were synthesized by the Rockefeller University
Proteomics Resource Center.
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2.14 Antibodies
Anti-dimethyl NS1 antibody (NS1me2) was raised in rabbits against peptides (220230) bearing pre-methylated K229 residue. Methyl specific antibodies were purified first
by pre-absorbing serum (1 out of 8 rabbits showed highly reactive methyl-specific serum
at the second bleed after peptide injection) to a matrix containing unmodified peptides,
followed by purification on a NS1me2 column. Anti-PB1 and anti-NP are custom made
antibodies kindly provided by P. Palese. Mouse anti-Flag is from Sigma (A8592);
antibody against hPAF1C subunits were all purchased from Bethyl laboratories: PAF1
(A301-047A); CTR9 (A301-385A); LEO1 (A310-048A); RTF1 (A300 179A);
Parafibromin/CDC73 (A300-170A); as well as CHD1(A301-218) and
SMARCAL1(A301-086). Anti-H3K4me3 was purchased from Millipore (17-614), while
Anti-RNA Pol II CTD (Ab5408) was purchased from Abcam. GST antibody was from
Roche (RPN1236V).

2.15 Differential salt extraction
A549 cells were seeded and subsequently infected with influenza virus. Cells were
then collected and nuclear pellets were prepared. Nuclear proteins were extracted from
these pellets by using increasing concentrations of NaCl from 10 mM up to 2 M in BC
buffer. Eluted materials were resolved on PAGE and immune-blotted with the specific
antibody.
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2.16 Chromatin-immunoprecipitation
We used a slightly modified version of described protocols to perform crosslinking
ChIP (Barski et al., 2007; Lee et al., 2006). Approximately 10 million cells were used for
each ChIP (5 times more material was used for Flag assay due to reduced performance of
anti-Flag antibody on cross-linked material). In brief, uninfected or influenza infected
A549 cells were fixed with 1% formaldehyde. The cross-linking reaction was stopped
after 10 min by the addition of 2.5M glycine to a final concentration of 0.125M in the
reaction. Cells were collected via scraping in ice cold PBS supplemented with protease
inhibitor cocktail (Sigma). Cross-linked chromatin was subjected to sonication with the
Biorupter (Diagenode), where we optimized sonication conditions to generate DNA
fragments approximately 300-500 bp in length. Immunoprecipitations were carried out
using antibodies pre-bound to either Invitrogen Dynal magnetic beads (Invitrogen
Dynabeads anti-mouse M-280 #112-02, or Dynabeads anti-rabbit M-280 #112-04, or
Dynabeads Protein A #100-02D). Following an overnight incubation, chromatin bound
beads were washed 8 times in a modified RIPA wash buffer (50 mM HEPES-KOH pH
7.6, 100 mM LiCl, 1 mM EDTA pH 8.0, 1% NP-40, 0.7% Na-Deoxycholate) before
being eluted into TE buffe containing 1% SDS 50 mM Tris-HCl pH 8.0, 10 mM EDTA
pH 8.0, 1% SDS). Protein bound chromatin complexes were then subject to overnight
cross-link reversal at 65°C. After RNase and proteinase K digestion, ChIP DNA and
input DNA were purified using the QIAquick PCR purification kit. DNA was eluted in
TE buffer before being subject to downstream analyses.
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2.17 ChIP-Sequencing
To prepare ChIP-sequencing libraries, we used 30ul of ChIP DNA and repaired
DNA ends to generate blunt-ended DNA using the Epicenter DNA ENDRepair kit
(Epicenter Biotechnologies, cat# ER0720). End-repaired DNA was purified using the
QIAquick PCR purification kit (28104). Following DNA end Repair, we added A bases
to the 3′ end of the DNA fragments using Klenow Fragment (NEB M0212L), and
purified DNA using the QIAGEN MinElute kit (28004). We ligated Illlumina/Solexa
adapters (#FC-102-1003) to DNA fragments overnight, using T4 DNA ligase (NEB
M0202L). Following overnight ligation, we purified adaptor-ligated DNA fragments with
the QIAGEN MinElute kit. To generate the final libraries for sequencing, we performed
18 cycles of PCR with Illumina/Solexa primers 1.0 and 2.0. We checked for fragment
size by loading 1/10 of our amplified library on a 1% agarose gel, and purified the
remaining ChIP-seq library using the QIAGEN MinElute kit. Purified library DNA was
used for cluster generation on Illumina/Solexa flow cells, and sequencing analysis was
performed on an Illumina/Solexa Genome Analyzer II following manufacturer protocols.

2.18 GRO-sequencing
Transcriptionally active nuclei from infected or untreated A549 cells were prepared
after swelling for 5 minutes the cells in ice-cold swelling buffer (10mM Tris (pH = 7.5),
2mM MgCl 2 , 3mM CaCl 2 ). Pelleted cells were re-suspended in 1ml lysis buffer (10mM
Tris (pH = 7.5), 2 mM MgCl 2 , 3mM CaCl 2 , 10% glycerol, 0.5% NP40,
2U/ml−1 SUPERaseIN (Ambion) and pipetted 20 times with a P1000 tip with the end cut
off to reduce shearing. Volume was brought to 10 ml with lysis buffer and nuclei were
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pelleted at 600g for 5min. Nuclei were washed in 10ml lysis buffer and re-pelletted. A
small aliquot was taken for Trypan blue staining to check that lysis occurred and nuclei
were still intact. Nuclei were resuspended in 1ml freezing buffer (50mM Tris-Cl (pH =
8.3), 40% glycerol, 5mM MgCl 2 , 0.1mM EDTA) using a P1000 tip with the end cut off
and re-pelletted and re-resuspended in 500μl of freezing buffer and aliquoted into 100μl
aliquots and frozen in liquid nitrogen. GRO-Seq libraries were then prepared as
described previously (Core et al., 2008).
SSPE, NaCl, KCL, EDTA, and water are DEPC treated, while SDS, Sarkosyl, DTT,
Tween, Tris buffers, PVP, NaOH were made with DEPC treated water, then filtersterilized. Buffers used for immunoprecipitation contain superRNAsIN (1μl per 5 ml
buffer) (Ambion) to block degradation that can occur during the experimental procedure.

2.19 Transcription Assay
In vitro transcription assays were done as previously described (Kim et al., 2010).
In brief, we used an highly purified transcription factors (Pol
II, TFIID, TFIIA, TFIIB, TFIIE, TFIIF, TFIIH, PC4, and Mediator) and a pML array
template that contains p53-binding sites nearby the core promoter and generates 390nucleotide transcription products. This system previously was shown to effect activatordependent transcription (Kim et al., 2010). Purified proteins used for this assay were
expressed recombinantly in a Baculovirus system in SF9 cells. Baculoviruses were
generated according to the manufacturer's instruction (GIBCO-Invitrogen). To get
purified proteins and/or complexes, SF9 cells were infected with combinations
of baculoviruses. Proteins/complexes were then affinity purified on M2 agarose.
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2.20 Bioinformatics used with high-throughput sequencing assays
Samples were sequenced in accordance with manufacturer protocols on GAIIx and
HiSeq2000 instruments. Image data was analyzed in real-time by the onboard RTA
software package.
Raw Data Analysis
Bcl files produced by RTA were converted to qseq files by Illumina’s OLB
software package, and qseq files converted to fastq for subsequent analysis.
ChIP-Seq Alignments
Sequencing reads were aligned to the Human March 2006 (NCBI36/hg18)
assembly using the short-read aligner Bowtie (Langmead et al., 2009). Reads were
aligned at 36bp allowing for 2 mismatches to the reference, reporting unique alignment
locations only. RefSeq annotation data was downloaded from the UCSC table browser.
RNA-Seq Analysis
Sequencing reads were processed using Tophat (Trapnell et al., 2009), a junction
mapping alignment program designed to identify splice junctions from RNA-Seq reads.
Briefly, the program aligns reads to a reference genome, identifying regions of coverage
that correspond to transcribed RNA. The underlying sequence of adjacent regions is
joined together to create a spliced reference, and reads that did not initially align to the
reference genome are aligned to identify sequencing reads that originated from potential
splice junctions (e.g. exon-exon junctions).The Cufflinks (Trapnell et al., 2010) software
package was used to perform gene expression level calculations and comparisons
between RNA-Seq libraries prepared from uninfected cells and infected cells.
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GRO-Seq Analysis
All sequencing reads were 51bp long. Reads that passed the internal Illumina
quality filter were processed for adapter trimming, and reads which were longer than
15bp after adapter removal were retained. This subset of reads was aligned allowing 2
mismatches to the reference. Reads which were not trimmed of adapter sequence were
truncated by 6bp at the 3’end to allow for potential incomplete adapter trimming, and
aligned allowing 3 mismatches to the reference. Duplicate alignment positions were
condensed to a single alignment entry to account for potential amplification biases. The
adapter-trimmed and no-adapter alignments were merged for all subsequent analyses. All
reads were aligned using the short-read aligner bowtie to the Human March 2006
(NCBI36/hg18) assembly.
Strand-specific coverage files were generated to differentiate between sense and
antisense transcripts and to facilitate proper assignment of enrichment information for
gene profiling.
GRO-Seq FPKM values were obtained by calculating the number of reads in the
transcriptional unit and reporting per kilobase of gene length per million mapped reads.
Integrated profiles (see the following Integrated ChIP-profile) were made reflecting
3kb upstream from the TSS and 3kb downstream from the TES and 300 internal
windows.
1000 genes were selected randomly from a group of 16,806 genes that had similar
gene body enrichment level ranges relative to genes in Table 2. The GRO-Seq data from
WT 12H was used for this selection.
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Integrated ChIP-Seq profiles
Genes were profiled 2.5kb upstream of the TSS, through the gene body and 2.5kb
downstream of the transcriptional end site (TES). Read counts were calculated in 100bp
windows up and downstream of the TSS and TES, and each gene was segmented in 300
internal windows. Plots were made using a 1kb moving average. Values are readnormalized and reflect the number of reads observed in each averaged window.
Genes were selected by requiring a log2 fold-change increase in expression of
greater than 2, PolII-Total ChIP-Seq enrichment increase throughout the gene body
(600bp downstream of the TSS to 3kb downstream of the TES) of greater than >1.4-fold
at 12 hours post infection compared to uninfected cells, and an H3K4me3 peak in either
uninfected cells or cells 12 hours post-infection (as determined by MACS (Zhang et al.,
2008) using custom settings for H3K4me3) within 3kb of the TSS. Additionally, genes
passing these criteria were filtered out if the TES of genes with higher than 2 FPKM
within 10kb of their TSS in an effort to minimize the effect of high RNA Pol II at the
TES of highly transcribed genes.
For NS1 ChIP-Seq in A549 infected siPAF1, siCHD1 and siCtrl conditions,
enrichment data was calculated for all RefSeq genes 5kb +/- TSS in 50bp windows, and
anti-Flag ChIP-Seq enrichment values from uninfected cells was calculated similarly and
subtracted. Values are read-normalized and reflect the number of reads observed in each
window.
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Peak Calling
To identify regions of ChIP enrichment, we used a custom JAVA/python/R peak
calling algorithm that is based on the well known SPP (Kharchenko et al., 2008) and
MACS2 (Zhang et al., 2008) algorithms. We first maximized the difference between the
input and IP signal over the transcription start sites (TSS) regions of the reference
genome to minimize false positive rates. A time series analysis of multiple time points of
the PAF1 and Pol II ChIP-seq libraries was then perform to achieve the final list of Pol II
or PAF1 bound regions.
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CHAPTER 3: SUPPRESSION OF THE ANTIVIRAL RESPONSE BY AN
INFLUENZA HISTONE MIMIC
3.1

Identification of putative histone mimics
The histone tails are composed of numerous overlapping short motifs that different

effector proteins can recognize and bind to. In order to address our hypothesis that
pathogens might have evolved similar motifs to interfere with host cellular regulation or
to gain selective advantages, we designed an in silico screen. We focused on viral
pathogens since they are obligate parasites which are known to rely heavily on host
machinery. We focused our efforts on a set of known human viruses (Table 3.1)
For the screen, we first compiled a series of short overlapping motifs between 4 to
10 amino acids long deriving from the N-terminal histone H3 tail (Figure 3.1). The
design and sequence of these motifs were influenced by the two following criteria:
(1) Search motifs were centered on known post-translational modification sites on the
histone H3 tail. We reasoned that these residues were most likely to be
encompassed within any putative motifs due to the fact that such sites often serve
as important docking and regulatory sites for effector proteins.
(2) Residue charge and propensity to be modified were factored in the design of the
putative motifs. For example, we allowed conservative serine –threonine
substitutions since several known histone kinases are able to modify both serine
and threonine residues on other substrates.
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Table 3.1: List of Viruses used for the in silico screen. Shown here are the viral
families, the genome type and the replication compartments of the viruses we used in our
in silico screen.
Genome Type

Family

dsDNA (RNA intermediate)

Hepadnaviridae
Adenoviridae
Poxviridae
Herpesviridae

Replication
Compartment
Nucleus
Nucleus
Cytoplasm
Nucleus

Papillomaviridae

Nucleus

Polyomaviridae

Nucleus

Parvoviridae

Nucleus

Hepatitis delta virus
Rhabdoviridae
Filoviridae

Nucleus
Cytoplasm
Cytoplasm

Paramyxoviridae

Cytoplasm

Bunyaviridae

Cytoplasm

Arenaviridae

Cytoplasm

dsDNA

ssDNA

ssRNA ( neg. polarity)

Orthomyxoviridae

Nucleus

Coronaviridae

Cytoplasm

Flaviviridae

Cytoplasm

ssRNA (pos. polarity)
Togaviridae

Cytoplasm

Picornaviridae

Cytoplasm

Caliciviridae

Cytoplasm

Hepeviridae

Cytoplasm

ssRNA (DNA intermediate)

Retroviridae

Nucleus

dsRNA

Reoviridae

Cytoplasm
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Virus
Hepatitis B virus
Human adenovirus 1,2,35,5,54,7, A,B,C,D,E,F
Vaccinia virus, Variola virus
Human herpesvirus 1,2,3,4,5,6A,6B,7,8
Human papillomavirus (types
116,10,101,103,108,109,112,121,126,128,129,131,132,134,135,
136,137,140,144,16,166,26,32,34,4,41,48,49,5,50,53,60,63,6b,7
,88,9,90,92,96)
BK polyomavirus, JC polyomavirus, KI polyomavirus,
Merkel cell polyomavirus, WU Polyomavirus
Human parvovirus 4, Human parvovirus B19, Adenoassociated virus (1,2,3,4,5,6,7,8), Human bocavirus
(1,2,3,4)
Hepatitis D virus
Rabies virus
Ebola virus - Mayinga Zaire 1976
Measles virus, Mumps virus, Hendra virus, Nipah virus,
Human respiratory syncytial virus, Human
metapneumovirus
Bunyamwera virus, Hantaan virus, Sin Nombre virus, Rift
Valley fever virus
Lymphocytic choriomeningitis virus, Lassa virus, Junin
virus, Machupo virus, Guanarito virus, Tacaribe virus,
Sabia virus, Lujo virus, Mopeia Lassa virus reassortant 29
Influenza A virus (A/Hong Kong/1073/99(H9N2)),
Influenza A virus (A/Korea/426/1968(H2N2)), Influenza A
virus (A/Korea/426/68(H2N2)), Influenza A virus (A/New
York/392/2004(H3N2)), Influenza A virus (A/Puerto
Rico/8/1934(H1N1)), Influenza B virus, Influenza C virus
(C/Ann Arbor/1/50)
Human coronavirus (229E, HKU1, NL63, OC43), Human
enteric coronavirus strain 4408, SARS coronavirus
Dengue virus (1,2,3,4), Hepatitis C virus, Hepatitis C virus
(genotypes 2,3,4,5,6), Tick-borne encephalitis virus,
Yellow fever virus, Modoc virus, Japanese encephalitis
virus, West Nile virus, St. Louis encephalitis virus,
Alkhumra hemorrhagic fever virus, Langat virus,
Powassan virus, Wesselsbron virus, Usutu virus, Murray
Valley encephalitis virus, Omsk hemorrhagic fever virus
Semliki forest virus, Sindbis virus, Venezuelan equine
encephalitis virus, Western equine encephalitis virus,
Eastern equine encephalitis virus, Chikungunya virus,
Rubella virus
Human enterovirus (100,107,98), Human rhinovirus B14,
Theilovirus, Foot-and-mouth disease virus (types A, Asia
1, C, O, SAT1, SAT2, SAT3), Hepatitis A virus
Sapovirus C12, Sapovirus Hu/Dresden/pJG-Sap01/DE, ,
Sapovirus Mc10
Hepatitis E virus
Human T-lymphotropic virus (1,2,4), Human
immunodeficiency virus 1 (1,2)
Mammalian orthoreovirus 3, Adult diarrheal rotavirus
strain J19, Rotavirus A, Rotavirus C

N-ARTKQTARKSTGGKAPRKQLATKAARKSAP
Methylation site

Acetylation site

Phosphorylation site

H3

ARTK
RTKQ
TKQT
etc.

H3-tail Motif
Library

> Influenza A | NS1
MSDNTVSS……..
ARSKV

Compare
(Substitutions allowed)

> HSV | E1A
MRHIICHG……..
CKRPRP

Curate
- Putative NLS?

Hits

- Crystal Structure?
- Known Function?

Viral protein
database
(human only)

Figure 3.1: Strategy for in silico screen for putative histone mimics. A series of
motifs deriving from the histone H3 N-terminal tail domain were compiled. This library
of motifs was screened against a database of proteins derived from known human
pathogens. We allowed certain conservative serine/threonine amino acid substitutions.
Potential histone-mimics were scored for motif proximity to the protein terminus and
manually curated for nuclear localization, structure and function in hosts. Histone
diagram adapted from Zhang and Reinberg, 2001
This compilation of motifs was then screened against a database of proteins derived
from known human pathogens (Figure 3.1, Table 3.1) in order to identify potential viral
histone mimics. Candidate proteins were ranked using a series of criteria. They were
ranked by similarity of the identified motif to the original H3 sequence, as well as the
proximity of the motif to either the carboxyl or amino terminus of the protein. In
addition, the top hits for each motif were manually scored for known cellular localization
as well as predicted or known function and structure. A list of some of our top candidate
hits for H3K4-, H3K9- and H3K27-like motifs can be found in Table 3.2.
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Table 3.2: Putative histone-like sequences found in known human pathogens. The
table shows the top candidate viral proteins that bear histone H3K4-, H3K9- or H3K27like motifs. The sequence of the identified motif and its distance from either the carboxyl
(C-) or amino (N-) terminal is indicated.
Distance from
Terminal
terminal

Accession

VIRAL PROTEIN

MOTIF

YP_308845.1
NP_042931.1
NP_819006.1
YP_012612.1
YP_006390078.1
YP_001491557.1
YP_081514.1
YP_001469632.1
YP_001469633.1
YP_001469630.1

H3K4- like sequences
nonstructural protein 1 [Influenza A virus (A/New York/392/2004(H3N2))]
DNA polymerase catalytic subunit [Human herpesvirus 6A]
E2 protein [Semliki forest virus]
attachment glycoprotein G [Human metapneumovirus]
truncated structural polyprotein [Semliki forest virus]
NS5b [Hepatitis C virus genotype 3]
envelope glycoprotein B [Human herpesvirus 5]
HCV polyprotein [Hepatitis C virus genotype 4]
polyprotein [Hepatitis C virus genotype 5]
polyprotein [Hepatitis C virus genotype 2]

ARSK
ARSK
ARSK
ARSK
ARSK
ARSK
ARSK
ARSK
ARSK
ARSK

4
72
31
23
106
97
257
494
494
494

C
N
C
N
C
N
N
C
C
C

Nuclear
Nuclear
Membrane
Membrane/Cytoplasm
Membrane/Cytoplasm
Perinuclear
Membrane/Perinuclear
Varied
Varied
Varied

AP_000576.1
YP_002213842.1
NP_040515.1
AP_000165.1
AP_000201.1
AP_000502.1
YP_001672011.1
YP_001974427.1
YP_001129382.1
YP_401712.1

H3K9- / H3K27-like sequences
pol [Human adenovirus 35]
DNA polymerase [Human adenovirus B]
encapsidation protein IVa2 [Human adenovirus C]
IVa2 [Human adenovirus 2]
IVa2 [Human adenovirus 5]
IVa2 [Human adenovirus 1]
E2 protein [Human papillomavirus type 88]
single-stranded DNA-binding protein [Human adenovirus D]
ORF29 [Human herpesvirus 8]
BALF5 [Human herpesvirus 4]

ARKS
ARKS
ARKT
ARKT
ARKT
ARKT
ARKS
ARKT
ARKT
ARKT

28
28
5
5
5
5
52
72
126
60

N
N
C
C
C
C
N
N
N
C

Nuclear
Nuclear
Nuclear
Nuclear
Nuclear
Nuclear
Nuclear
Nuclear
Nuclear
Nuclear

3.2

Localization

Influenza Non-Structural Protein 1 (NS1) from H3N2 subtype bears a histone
mimic
One of our top candidate hits was the Non-Structural Protein 1 (NS1) sequence

derived from the A/New York/392/2004(H3N2) strain of influenza A virus. Our screen
showed that the NS1 protein carried the sequence 226-ARSK-229. This sequence
strongly resembled the first 4 amino acids of the histone H3 protein 1-ARTK-4 (Figure
3.2). Strikingly, comparison of H3 and NS1 structural data showed that both these
sequences were localized to the unstructured terminal tails of their respective proteins,
indicating that the NS1 histone-like sequence was located in a similar structural context
as the histone H3 tail.
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NH2

Histone H3

Influenza NS1
Histone H3
NS1
Strain
H3N2
H1N1
H5N1
H1N1
H1N1

1
221

COOH
ARTKQTARKS
KMARTARSKV

Year of appearance

NS1 COOH-terminal
216

1968-2011
1933-2011
2003
1918*
2009*

10
230

216
216
216
216

PKQKRKMARTARSKV
PKQKRKMARTIRSEV
PNQKRKMARTIESEV
PKQKRKMARTIKSEV
PKQK-----------

230
230
230
230
219

* Influenza pandemic strains

Figure 3.2: H3N2 Influenza A NS1 contains a histone mimic. The homologous
carboxy-terminal NS1 and the amino-terminal histone H3 sequences are shown (red
letters). The table displays C-terminal NS1 sequences of the influenza A subtypes.
We were also particularly intrigued by the NS1 protein it does not play a structural
role in the influenza virion. Rather, its main function is to suppress the immune response
during infection (Egorov et al., 1998; Garcia-Sastre et al., 1998; Kochs et al., 2007) and
viruses lacking a functional NS1 protein are highly attenuated in immune-competent
hosts (Garcia-Sastre et al., 1998). Depending on the Influenza virus subtype, it can vary
from between 230 to 237 amino acids long (Palese P, 2007; Suarez and Perdue, 1998),
although C-terminal truncations of 15-30 amino acids have also been reported (Suarez
and Perdue, 1998). The protein can be divided into three functional domains: an Nterminal RNA binding domain (residues 1-73) (Chien et al., 1997; Hale et al., 2008b;
Hatada and Fukuda, 1992), a C-terminal effector domain (residues 74-210) (Bornholdt
and Prasad, 2006; Hale et al., 2008a). As alluded to earlier, the last 20 amino acids
(hereafter referred to as NS1 ‘tail’) of the effector domain (residues ~207-230) appear to
be disordered, and are not observable in crystal structures of the NS1 effector domain
(Hale et al., 2008a).
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To understand whether the NS1 histone-like sequence was well conserved amongst
influenza A virus isolates, we obtained 2753 unique full-length NS1 sequences from the
NCBI influenza virus resource. Of these sequences, 1737 were derived from avian
isolates, 250 were from swine isolates and 766 were from human isolates. Multiple
sequence alignment of these proteins showed that the RNA binding, and C-terminal
effector domain of the NS1 protein is generally very well conserved between viral
isolates. In contrast, the C-terminal ‘tail’ domain, where the NS1 histone mimic was of
the NS1 protein displayed poor sequence conservation (Figure 3.3A).
Influenza A viruses are typically categorized into subtypes based on hemagglutinin
and neuraminidase serotype on their viral envelopes (Bouvier and Palese, 2008; Palese P,
2007). As such, when we broke our analyses down to subtype, we found that the NS1
histone-like sequence was highly conserved among influenza A isolates of subtype
H3N2, but was not found in other subtypes (i.e. H1N1, H5N1) of human influenza A
virus (Figure 3.2 and Figure 3.3C). This sequence was not found in any of the avian
strains of influenza virus (Figure 3.3B). Altogether, this suggested that the NS1 histonelike sequence could be a strain- and human-specific virulence factor.
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Figure 3.3: Conservation of NS1 histone-like sequence. A. Conservation of NS1
proteins within human, avian and swine isolates of influenza A virus. Green: High
conservation score, Red: Low conservation score. B. Percentage of unique human, swine
or avian NS1 sequences that carry the H3N2 NS1 tail (“KMARTARSKV”) or the histone
H3-like sequence (“ARSK”) C. Abundance of NS1 histone-like sequence within different
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3.3

NS1 is recognized by histone modifying enzymes
We hypothesized that the similarity of the NS1 tail to the histone H3 N-terminal tail

would allow it to be recognized and modified by cellular histone modifying enzymes. To
address this, we utilized three different approaches. In our first approach we incubated
NS1 tail-peptides with known histone modifying enzymes and complexes. Notably, NS1
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was methylated by the recombinant Set9 and Set1 complexes (Figure 3.4A), which
specifically modify H3K4. Recombinant NS1 that carried a lysine to arginine mutation
on residue 229 could not methylated by either Set1 or Set 7/9, showing that methylation
occurred site-specifically. Similarly, acetyltransferase assays revealed that NS1 could
also be acetylated at residue 229 by Tip60 complex, another known H3K4
acetyltransferase (Xhemalce and Kouzarides, 2010) (Figure 3.4A, top panel) In a similar
vein, recombinant full-length NS1 expressed in bacteria incubated with the same cellular
histone modifying enzymes and complexes was post-translationally modified in vitro.
These modifications were also dependent on lysine 229 on the NS1 tail and mutation of
lysine into an arginine resulted in the loss of post-translational modification (Figure 3.4A,
middle panel).
We next sought to determine whether NS1 is modified in the context of a viral
infection. To determine if methylation and acetylation of NS1 occurs during infection,
cells were infected with either wild type (WT) virus or a virus bearing a lysine to arginine
mutation at residue 229 in NS1 (K229R). NS1 methylation was detected with an NS1methyl specific antibody that we raised (Figure 3.4B), whereas NS1 acetylation was
detected by a pan-acetyl antibody. These experiments showed that NS1 is indeed
methylated and acetylated in cells during viral infection. As expected, methylation and
acetylation occurred on lysine 229 on the NS1 protein. NS1 isolated from K229R
infected cells was not methylated or acetylated (Fig 3.4A, bottom panel). Together, these
data show that NS1 is recognized by site-specific histone modifying enzymes, and can be
post-translationally modified by these proteins.

49

A

B
Set1C
wt

KR

Set7/9
wt

TIP60

KR

wt

NS1
un me1 me2 me3

KR
NS1
Peptide

103
102
100

wt

KR

wt

KR

wt

KR
10-1

GST-NS1

−

wt

KR WB:
NS1me2

−

wt

KR WB:
NS1ac

NS1

NS1

[pmol]

Infected
A549 cells

Figure 3.4: NS1 is modified by histone modifying enzymes. A. Methylation or
acetylation of the NS1 peptide (top panel), the GST–NS1 protein (middle panel) or of
viral NS1 in infected A549 cells (bottom panel) are shown. B. Characterization of the
K229 methyl-specific anti-NS1 antibodies. Unmodified (un), or synthetically methylated
(K229me1, me2 or me3) NS1 peptides were serially diluted at indicated concentrations
and spotted on a nitrocellulose filter. The binding specificity was tested by dot-blot
analysis using affinity purified methyl-specific rabbit NS1 antibody. The results show the
specificity of the NS1K229 di-methyl specific antibody (anti-NS1me2). WT: wild-type
NS1 sequence; KR: NS1 substrates where K229 is replaced by arginine; me1: Monomethylation; me2: Di-methylation; me3: Tri-methylation; ac: Acetylation

3.4

NS1 is bound by PAF1 complex
Based on these results, we hypothesized that histone mimicry in NS1 would allow

NS1 to interact with host histone-binding proteins, which in turn could be important for
NS1 function. We thus sought to identify NS1 tail interactors by performing an unbiased
peptide pull down screen. Briefly, nuclear extracts from HEK293 cells were fractionated
over a heparin column and each resulting fraction was incubated with a peptide carrying
the NS1 tail sequence. A scrambled control peptide, which had an identical amino acid
composition to the NS1 tail, was used as a binding control. NS1 tail binding proteins
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were separated by PAGE and visualized on a gel. Protein bands that were differentially
bound between the NS1 tail peptides and its scrambled control peptide were than excised
and subjected to tandem mass spectrometry (Figure 3.5A, left panel). A large number of
peptides we found belonged to proteins that were derived from several complexes known
to be associated with transcription and co-transcriptional activities. These included
members of the human PAF1 transcription elongation complex (PAF1C), as well as the
CHD1 chromatin-remodeling complex (Figure 3.5A, right panel).
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SNF2l
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Figure 3.5: Identification of NS1 tail interacting proteins. A. Schematic depicting of
affinity purification of NS1 “tail”-binding nuclear proteins (left panel). NS1 binding
proteins were identified by affinity purification of HEK293 nuclear extracts and NS1
bound proteins were separated by PAGE and visualized by colloidal coomassie staining.
Proteins that displayed differential binding to the NS1 "tail" and scrambled control
peptides were extracted from the gel and analyzed by mass spectrometry. Association of
the NS1 histone mimic with the PAF1C subunits and CHD1 in nuclear extracts (right
panel). wt: Wild-type NS1 sequence; IP: Immunoprecipitation B. NS1 histone mimic
binds to CHD1. Unmodified (un) or methylated (me) NS1 or H3(K4) peptides were
incubated with recombinant full length CHD1 or the CHD1 double-chromodomain.
Peptide binding was revealed by either silver staining or Coomassie staining.
We next used in vitro assays to reveal the primary binder of the NS1 protein. Of the
proteins we identified, only CHD1 was previously shown to interact, albeit in a
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methylation-dependent fashion to histone H3 (Sims et al., 2005). In support of the histone
mimicry within the NS1 tail, CHD1 protein did not appear to directly interact with the
unmodified NS1 tail peptide (Figure 3.5B). Instead, we saw that methylated forms of the
NS1 tail peptide were able to interact well with human CHD1 protein, which had been
identified as a reader of di- and tri- methylated H3K4 (Sims et al., 2005). Both full length
human CHD1 and its purified chromodomain were found to interact with methylated NS1
tail peptide, but not to the unmodified or acetylated NS1 tail (Figure 3.5B).
We thus turned our attention to PAF1C because of several factors. The PAF1C has
been shown to coordinate several steps in RNA polymerase II mediated transcription
(Chen et al., 2009; Kim et al., 2010; Kim and Roeder, 2009; Mueller et al., 2004; Nordick
et al., 2008), and has been shown to be a platform through which many other critical
transcription regulatory factors may bind to (including CHD1) (Jaehning, 2010). PAF1C
had also previously been implicated in the regulation of stress-induced genes in yeast
(Betz et al., 2002; Kim and Levin, 2011), suggesting that it had a role in inducible gene
expression. We were thus interested in further exploring the interactions between PAF1
and NS1

3.5

The PAF1 complex binds to the NS1 histone-like sequence
To prove that NS1 tail was directly binding to the PAF1 complex, we first assessed

the ability of biotinylated NS1 tail peptides to bind to purified PAF1 complex in vitro.
Our assay showed that the NS1 tail was sufficient to pull-down the PAF1 complex by
immunoprecipitation (Figure 3.6B)
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The human PAF1C is composed of six subunits – PAF1, CTR9, LEO1, RTF1,
CDC73 and SKI8 – that bind together cooperatively to form the complex (Kim et al.,
2010) (Figure 3.6A). However, both loss-of-function and mutational studies have
suggested that there are distinct roles for the specific subunits within the complex, with
each subunit binding to and interacting with different cellular partners(Betz et al., 2002;
Mueller et al., 2004; Piro et al., 2012). Thus, to assess the primary binder(s) of the NS1
tail within the PAF1C, we incubated the biotinylated NS1 tail peptide with individual
purified, Flag-tagged PAF1C subunits. The results of this experiment indicated that the
PAF1 subunit is the primary binder of the NS1 tail. This binding was specific to the NS1
tail sequence, as a scrambled version of this peptide did not promote PAF1 binding. NS1PAF1 association was also not strongly affected by methylation of K229 in the NS1
peptide, but was ablated by acetylation (Figure 3.6C).
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Figure 3.6: NS1 tail binding to recombinant hPAF1C and individual PAF1C
subunits. A. Schematic of the human PAF1 complex (adapted from Kim et al., 2010)
showing the binding interactions between the individual PAF1C subunits. Solid lines:
stable associations; dotted lines: weak interactions B. Binding of NS1 peptides to
recombinant hPAF1 complex. C. Binding of NS1 peptides to individual Flag-tagged
hPAF1C subunits to NS1. For pull-downs, hPAF1 complex and individual hPAF1C
subunits were prepared as described previously and incubated with the biotinylated NS1
peptides. Binding was assessed by western blotting. IP: immunoprecipitation; in: Input,
ctrl: Control scrambled peptide; un: Non-modified; me1: mono-methylated; me2: dimethylated; me3: tri-methylated; ac: acetylated
Our experiments with the NS1 tail peptide also suggested that histone H3 might
have similar interactions with PAF1C. Indeed, we found that unmodified and methylated
H3 tail peptides, but not the scrambled control or acetylated peptides could bind to
purified PAF1C or the PAF1 protein (Figure 3.7). Altogether these results highlight the
similarity between the NS1 tail and the histone H3 tail.
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Figure 3.7: Histone H3 tail binding to recombinant PAF1C and its individual
subunits. A. Binding of H3 peptides to recombinant hPAF1 complex. B. Binding of
individual Flag-tagged hPAF1C subunits to H3. IP: immunoprecipitation; in: Input, ctrl:
Contrl scrambled peptide; un: Non-modified; me1: mono-methylated; me2: dimethylated; me3: tri-methylated; ac: acetylated
3.6

NS1 is co-localizes with PAF1 on chromatin
In infected cells, NS1 is expressed with a predominantly nuclear localization

(Figure 3.8A). It is expressed at high levels, with an estimated 5x105 molecules per cell
(Figure 3.8B). While it was possible that NS1 retains a nucleoplasmic role in the infected
cell, the presence of the histone-like sequence in NS1, together with its ability to bind to
complexes involved in transcription elongation, suggested that NS1 could also have
chromatin related functions. Indeed, nuclear salt-extraction profiles of NS1 from infected
cells revealed that NS1 is associated with chromatin (Figure 3.8B).
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Figure 3.8: Nuclear localization and expression of NS1 protein in infected cells A.
Immunostained NS1 (red) co-localizes with DAPI-positive (blue) nuclei in A549 cells at
12h after infection. B. The amounts of NS1 in serially diluted nuclear extracts of A549
cells were determined by Western blotting and compared to defined amounts of
recombinant NS1. The amount of NS1 protein per cell was calculated based on
Avogadro’s equation (NA = N/n). C. The NaCl-elution profiles of NS1, β-actin and
histone H3 are shown. The amount of indicated proteins in eluates was measured by
Western blotting.

To facilitate further biochemical analysis of the NS1 protein, we knocked-in a Flag
allele into NS1 using A/Wyoming/2003(H3N2) strain as a background (Flag-NS1)
(Figure 2.1). This virus was infectious, and did not display any overt growth defects
when compared to its untagged wild-type background, indicating that the 3X-Flag on the
NS1 protein did not interfere significantly with viral biology (Figure 3.9).
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Figure 3.9: Flag-NS1 virus is infectious and displays no overt growth phenotype
Flag-NS1 recombinant virus supports infection and replication. A549 cells were infected
with the wild-type or recombinant influenza virus that expresses Flag-tagged NS1. The
virus functionality in single-cycle experiments was determined by expression of the viral
nucleoprotein (NP) and NS1 in infected A549 cells (upper panel), by degree of upregulation of the ISG15 and MX1 virus-induced genes in infected cells (middle panel) or
yields of viruses propagated in MDCK cells (lower panel).

We infected cells with the Flag-NS1 virus and performed genome-wide chromatin
immune-precipitation sequencing (ChIP-seq) experiments on Flag-NS1 binding. Since
PAF1 has been implicated in transcription elongation, we reasoned that NS1 binding was
likely to coincide with active gene transcription. We thus prepared ChIP-seq libraries for
Pol II, PAF1 and H3K4me3 in the infected and non-infected cells. In addition, in order to
identify genes that were induced upon infection, we performed RNA-sequencing. By
cross-referencing the Pol II ChIP-seq libraries and the RNA-seq libraries, we were able to
identify the subset of genes that were inducibly transcribed upon Influenza A infection.
Assessment of NS1 binding on infection inducible genes revealed that NS1 binding
was enriched at the transcription start sites (TSS), with slight enrichments within the gene
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body (Figure 3.10, top panel). This paralleled the enrichment profiles of both RNA
polymerase II (Pol II) and PAF1 protein on these genes, indicating that NS1 was colocalized with those two factors (Figure 3.10).

Figure 3.10: NS1 co-localizes with Pol II and PAF1 on chromatin The ChIP-seq
profiles show the distribution of indicated proteins at inducible genes before (black line)
and after (red line) infection. The induced genes were revealed by RNA-seq and ChIPseq analysis of infected A549 cells. TSS and TES, the transcriptional start and end sites,
respectively.
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3.7

PAF1-binding activity of NS1 impacts hosts transcription elongation
The presence of NS1 at the antiviral genes suggested that NS1 would be in position

to interfere with the recruitment and/or activity of PAF1 and Pol II at these loci. To
differentiate between these possibilities, we performed ChIP experiments for Pol II and
PAF1 in cells that were infected with either the wild type or ΔPAF viruses. Pol II and
PAF1 abundance was then assayed at the transcriptional start sites (TSS) and
transcriptional end sites (TES) of two known NS1-bound genes, IFIT1 and IFI6. In
general, Pol II and PAF1 levels at these two genes were lower in wild-type infected cells,
compared to ΔPAF-infected cells (Figure 3.11). However, the differences in Pol II and
PAF1 binding between wild-type and ΔPAF virus infected cells were much more
pronounced at the TES than at the TSS of these genes. Larger reductions of Pol II at the
TES compared to the TSS are usually indicative of inhibition of transcription elongation,
suggesting that this process could be impaired in wild-type infected cells.
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Figure 3.11: NS1 histone mimic is required for PAF1 and Pol II recruitment to
chromatin PAF1, RNA Pol II and H3K4me3 levels at the TSS and TES of the induced
genes in uninfected (ui) cells, cells infected with the wild-type (WT) or PAF1-binding
mutant virus (ΔPAF). Data are representative of three independent experiments; error
bars show the s.e.m.
ChIP experiments are useful for quantifying the amount of bound Pol II on the
DNA, but they are unable to distinguish between transcriptionally engaged and inactive
forms of Pol II. In fact, the decreased accumulation of Pol II at the at the IFIT1 and IFI6
TES as compared to the TSS, may either reflect inefficient transcription elongation, or be
a result of an accumulation of transcriptionally paused and/or arrested Pol II at the TSS of
the gene.
As such, to better understand the impact that the NS1 tail mimic had on antiviral
gene transcription, we performed Global Run-on sequencing (GRO-seq) experiments on
cells infected with either the wild-type or ΔPAF viruses. Metagene profiles of our GROseq data showed that in the absence of infection, the majority of the anti-viral genes are
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transcriptionally silent, with low levels of active polymerases accumulating downstream
of the TSS (Figure 3.12A). Many of these genes also retain a 5’ peak of promoter
proximal paused polymerase. Upon infection with either the wild-type virus or the ΔPAF
virus, we saw an increase of active Pol II accumulate at both at the TSS and within the
gene bodies of the antiviral genes. However, increase of active Pol II was significantly
lower in wild-type infected cells as compared to that in ΔPAF infected cells (Figure
3.12A).
The differences in active Pol II accumulation between wild-type and ΔPAF infected
cells also appeared to be specific to antiviral genes. Metagene profiles comparing wildtype and ΔPAF infected cells displayed no differences in Pol II accumulation at noninducible genes, suggesting that the NS1-PAF1 interaction might be specific to infectioninducible genes only (Figure 3.12B).
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Figure 3.12: NS1 suppresses antiviral gene transcription in infected cells A. Left: the
GRO-seq-measured RNA transcripts in uninfected (ui) A549 cells (black line) or cells
infected with wild-type or ∆PAF virus (green and red lines, respectively) . Right: GROseq profile of IFIT1 and IFI6 genes in uninfected and infected cells. B. GRO-seq profile
of A549-expressed genes that are not affected by virus infection (left panel) or of the
HPRT1 gene (right panel). Reads from either DNA strands are indicated as +/− . The y
axes display reads per million mapped reads per 25 bp.

3.8

NS1 histone like sequence affects antiviral gene expression
Our experiments with ChIP and GRO-seq suggested that transcription elongation

might be impaired in cells that were infected with virus expressing wild-type NS1. To
determine whether this defect was specific to the interaction between PAF1 and NS1, we
performed in vitro transcription elongation assays where purified general transcription
factors, transcription factors, co-activators and Mediator (Pol II, TFIID, TFIIA, TFIIB,
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TFIIE, TFIIF, TFIIH, PC4 and Mediator) are used in conjunction with a chromatinized
DNA template in vitro (Kim et al., 2010) (Figure 3.13A). In these assays, transcription
elongation efficiency is measured by the generation of the full-length 390-nucleotide (nt)
product from template.
Results from this assay indicated that NS1 strongly inhibited transcription
elongation activity of PAF1C. As expected, addition of PAF1C to the reaction results in
the accumulation of the 390 nt transcription elongation product (Figure 3.13B, lanes 1
and 2). This accumulation is reduced upon addition of purified NS1 to the reaction. In
contrast, use of purified NS1 that lacks the PAF-binding (NS1(∆PAF )sequence had little
effect on PAF1c mediated transcription (Figure 3.13B, lanes 3). Altogether these results
support the notion that NS1 tail sequence may function to interfere with PAF1C activity
(Figure 3.13B, lanes 4).

Figure 3.13: NS1 inhibits transcriptional elongation in vitro A. The full-length NS1
protein (NS1) or NS1 lacking the PAF1-binding sequence (NS1(∆PAF)) was added to the
RNA elongation reaction as indicated. B. The amount of the 390-nt RNA elongation
product was quantified by ImageJ. The results of two independent experiments are
shown.
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3.9

PAF1 is required for the induction of the inflammatory response
The results in GRO-seq suggested that PAF1C might be involved in the up-

regulation of the antiviral response. As such, we sought to study the impact that the
PAF1C has on influenza-induced gene expression. To do so, we infected PAF1 deficient
cells with NS1-null influenza virus (PR8/ΔNS1). We selected this virus as a precaution
against potential NS1-PAF1 cross talk. This virus was also particularly useful because it
induces an extremely strong antiviral response in host cells (Garcia-Sastre et al., 1998),
allowing more subtle effects of regulatory factors on the antiviral response to be
visualized easily (Shapira et al., 2009). For these sets of experiments, we chose to use a
high multiplicity of infection (MOI) to reduce potential paracrine signaling events. We
also limited our experiments to single-cycle infections.
Unexpectedly, despite being commonly thought of as a general transcriptional
activity in the cell, PAF1 deficiency does not cause overt changes to gene expression in
cells at steady state with expression levels of most housekeeping genes remaining
unchanged between PAF1 siRNA (siPAF) treated and non-targeting control siRNA
(siCtrl) treated cells (Figure 3.14).
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Figure 3.14: PAF1 is not essential for housekeeping gene expression. Expression
levels of indicated housekeeping genes were determined by microarray analysis of RNA
derived from un-transfected (ut), siPAF or siCtrl transfected cells. Results for individual
probesets are shown for genes that are represented by multiple probesets on the
microarray.
Infection of siCtrl and siPAF treated cells with PR8/ΔNS1 infection revealed that
there were similar numbers of up- and down-regulated genes in both the siCtrl and siPAF
treated cells. However, a subset of infection up-regulated genes appeared to be sensitive
to PAF1 depletion. These genes, which were highly enriched in key antiviral genes
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(including IL28A, IL28B, IL29, DDX58/RIGI), were induced to lower levels in siPAF
treated cells as compared to siCtrl treated cells (Figure 3.15A). Further qPCR analysis on
several of these genes validated our findings in microarray (Figure 3.15B).
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Figure 3.15: PAF1 controls antiviral response. A. The expression levels of mRNAs in
influenza infected control (siCtrl) or PAF1-deficient (siPAF) A549 cells. The table shows
top siPAF-affected gene categories as identified by IPA. ut, untreated with siRNA. B.
qPCR analyses of anti-viral genes in siCtrl, siPAF and ut cells. The fold difference
between levels of hPAF1 mRNA (upper panel) and host mRNA up-regulation were
measured by quantitative real time PCR of RNA isolated from infected A549 cells.
To determine whether the changes we saw in siPAF-sensitive genes could be
attributed to alterations in viral gene expression, we quantified the levels of viral mRNA
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and viral genomic RNA in siPAF and siCtrl cells. We found no significant changes in the
expression of virally-derived RNAs, suggesting that the differences we saw in antiviral
gene expression were not likely to be a result of an altered potential of the virus to induce

Expression Level

the inflammatory response in siPAF and siCtrl cells (Figure 3.16).

Viral genomic RNA

Viral messenger RNA

Figure 3.16: PAF1 does not control production of viral RNAs in PR8/ΔNS1 infected
cells. The levels of the indicated influenza genomic (upper panel) or messenger RNAs
(lower panel) were measured by qPCR analysis of RNA derived either from uninfected
(ui), PAF1-deficient (siPAF1) or control (siCtrl) A549 cells infected with PR8/ΔNS1
viruses. Data are representative of 3 independent experiments. Error bars represent the
S.E.M.
Similar to PR8/ΔNS1 infected cells, we found that antiviral gene expression was
reduced during infection with the NS1 bearing parent strain of PR8/ΔNS1, A/PR/8/34 as
well as during infection with a non-related virus vesicular stomatitis virus (VSV) (Figure
3.17). These results suggested that PAF1 requirement in the antiviral response was not
specific to influenza virus. Thus, to understand if active viral replication was required for
siPAF1 mediated effects on gene expression, we treated PAF1 deficient cells with
defined amounts of either IFNβ (a major cytokine regulating the antiviral response) or
Poly(I:C) (chemical mimetic of viral genomic RNA). (Figure 3.17) Analysis of these
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experiments showed that similar to infected cells, the expression of IFNβ and Poly(I:C)
induced genes was reduced in PAF1 deficient cells. Altogether, these data suggested that
PAF1 was required for the proper induction of stimulus responsive genes.
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Figure 3.17: hPAF1C controls antiviral gene expression in response to various
stimuli. The expression levels of antiviral genes were measured by microarray analysis
of RNA isolated from wild-type influenza H1N1 (left panel), vesicular stomatitis virus
(VSV) (middle panel), IFNB1 treated (top right panel) or Poly(I:C) treated (lower right
panel) A549 cells that were either not transfected (ut) or transfected with control (siCtrl)
or hPAF1 (siPAF) specific siRNAs. The tables show the top five functional categories of
the siPAF affected genes as identified by IPA.
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The inability of siPAF1 treated cells to mount a full antiviral response during
infection suggested that siPAF1 deficient cell populations would be highly susceptible to
viral infection. Accordingly, when siPAF1 and siCtrl treated cells were infected at an
m.o.i of 0.01 with PR8/ΔNS1 in a multi-cycle infection; we saw a log fold increase of
viral yield (Figure 3.18). On the other hand, depletion of CHD1, which we had also found
in our screen, had little effect on viral growth (Figure 3.18).
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Figure 3.18: Dynamics of virus replication in control or PAF1-deficient A549 cells.
Shown are the viral growth kinetics of Influenza infected cells. p.f.u. plaque-forming
units. Data are representative of three independent experiments. Error bars show the
s.e.m.
3.10 Conclusions
In summary, we found that the NS1 protein of the H3N2 subtype of Influenza virus
carries a histone H3-like sequence in its C-terminal tail domain. This sequence is required
for the virus to interact with the host PAF1C, and in doing so limit the host anti-viral
response by impairing PAF1C function (Figure 3.19). Lastly, we have used this host-
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pathogen interaction to uncover the central role of transcription elongator complex PAF1
in the proper induction of the immune response.

NS1

RNAPII
PAF1

RNAPII
PAF1

NS1

inhibitionof complex
function

↑ viral growth
↓ anti -viral genes

Figure 3.19: Putative Model of NS1: PAF1C interaction. NS1 histone-like sequence is
required for NS1 to interact with the PAF1C. PAFC1 function is inhibited upon NS1
binding, resulting in reduced production of anti-viral genes, and increased viral spread.
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CHAPTER 4: DYNAMICS OF PAF1 RECRUITMENT ON CHROMATIN
DURING THE ANTIVIRAL RESPONSE
4.1

Preamble
Our studies involving Influenza NS1 and its histone mimic highlighted the specific

role of PAF during viral infection. In fact, even though the PAF1C is considered to be a
general RNAPII associated elongation factor, our analysis showed that the depletion of
PAF1 in cells only had a very selective impact on the expression on anti-viral genes. As
such, the goal of this part of the study was the elucidate characteristics of these PAF1target genes. For these studies, we chose to use infection with PR8/∆NS1 as our
experimental system. This system was specifically chosen because this virus is a very
potent inducer of the antiviral response, and whose selective impact on the antiviral genes
can be ascribed efficiently. We predicted that PAF1 recruitment and activity is
differentially regulated on the induced anti-viral genes compared to non-induced, noninfection related genes.

4.2

Dynamics and Specificity of PAF1 binding during infection
In order to understand the specific requirements of PAF1 recruitment to chromatin

during infection, we performed ChIP-sequencing analysis of PAF1 binding sites from
uninfected and PR8/∆NS1 infected cells. We chose to use both early (4 hours post
infection) and a late (12h hours post infection) time points in this analysis to gain better
understanding of the dynamics of PAF1 binding.
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To determine the effects of infection on genome-wide PAF1 binding we took an
unbiased approach and used a customized peak caller program (see Methods) to identify
all PAF1 bound regions across the genome. We did encounter some limitations in the
program for detecting very broad regions of binding on chromatin and were unable to
completely avoid instances where a single large region of PAF1 binding was broken into
several smaller regions. Despite this, our approach appeared to be robust, with 98% of
genes that were bound by PAF1 being associated with a maximum of three PAF1 peaks
per gene. Two examples of the input raw sequence reads and the regions that have been
identified as PAF1 bound is shown in Figure 4.1A.
Overall, we were able to map at least 9550 loci across the genomes which are
associated with PAF1 binding in infected or uninfected cells. A majority (86%) of these
loci were associated with genic regions, with 46% of the called peaks localized to intragenic sites (i.e. within the gene body); 5% localized to areas around the transcription
termination sites and 32% localized to areas around the transcription start sites and
promoter regions of genes (Figure 4.1B). In contrast, only about 17% of these PAF1
bound loci were found in inter-genic regions. The mostly genic association of PAF1 is
consistent with the known association of PAF1 with RNA polymerase II, and its function
as a key player in transcription elongation and other co-transcriptional processes.
Next, we investigated the overall regulation of PAF1 binding throughout the course
of infection. PAF1 localization across the genome appeared to be fairly stable during
infection, with only 2 to 4% of loci showing differential recruitment of the PAF1 protein
during infection (Figure 4.1C). In fact, only a total of 198 loci at 4 hours post-infection,
and 403 sites at 12 hours post-infection showed at least a 2-fold change in PAF1 binding.
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Of these sites, the majority of the changes occurred in intragenic regions and was
associated with an increased level of PAF1 binding at the loci. On the other hand, the
numbers of sites that lost or gained PAF1 binding within the TES, TSS and intergenic
regions were similar to each other (Figure 4.1C).
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Figure 4.1: Genome-wide distribution of PAF1 binding. A. Genome browser view of
PAF1 binding at the IFIT locus (top panel) and the HIST1H1C locus (bottom panel) in
uninfected cells, and infected cells 4 hours (4h) and 12 hours (12h) post infection. PAF1
bound regions that were called using our customized peak finder program are highlighted
in black boxes above the genes. B. Classification of PAF1 bound regions based on their
overlap with transcription start sites (TSS), transcription termination sites (TES),
intragenic regions (including introns and exons), as well as intergenic regions. C.
Numbers of PAF1 bound loci that display at least a 2 fold increase in PAF1 binding at 4
hours or 12 hours post infection. PAF1 bound loci are classified as described in B.

4.3

PAF1 is strongly enriched on antiviral genes upon infection
We next scrutinized the PAF1 bound loci that displayed differential recruitment of

PAF1 during infection. Since the majority of sites that show changes in PAF1 binding
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during infection occur within genic regions (TSS, intragenic, TES), we decided to focus
our efforts on gene-associated PAF1 bound regions.
At 4 hours post infection, genic loci that displayed at least a 2-fold change in PAF1
binding were associated with a total of 59 genes (Figure 4.2A). Of these 59 genes, 58
displayed an overall increase in PAF1 binding, whereas 1 gene displayed a loss in PAF1
binding. Similarly, a total of 126 genes were associated with a change in PAF1 binding at
12 hours post infection. Of these genes, 116 genes were associated with an increase in
PAF1 binding, whereas 8 genes displayed a loss of PAF1 binding upon infection (Figure
4.2B, Left and Right panels).
To determine if genes that lose or gain PAF1 upon infection belong to identifiable
groups, we carried out pathway analyses on these genes. Genes that displayed an increase
in PAF1 binding either at 4 hours and/or a 12 hours post infection were highly enriched
in genes associated with inflammatory and antimicrobial response (Figures 4.2C and
4.2D), which are both impacted by Type I interferon signaling(Stetson and Medzhitov,
2006) . Consistent with this, we also saw the presence of many known interferon
stimulated genes (Schoggins et al., 2011) amongst the genes that actively altered PAF1
binding during infection (Figures 4.2A and B). In addition, we found an
overrepresentation of NF-κB and IRF binding sites at the promoters of genes that had
altered PAF1 binding during infection (Figure 4.2E). In contrast, these factors were not
identified in a set of randomly chosen genes (Figure 4.2E). Since both IRFs and NF-κB
are important for the activation of inflammatory genes, this observation further
underscored the specific recruitment of PAF1 to anti-viral and inflammatory genes during
infection.
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Figure 4.2: Changes in PAF1 recruitment at genes during infection. A. Genes that
display ≥2 fold change in PAF1 binding at 4 hours post infection. Increased PAF1
binding is shown in red and decreased PAF1 binding is shown in blue. ISGs (Schoggins
et al., 2011) are indicated by grey boxes on the right of the heatmap. B. Same as in A, but
for PAF1 binding at 12 hours post infection. C. Top five functional categories associated
with genes that are differentially bound by PAF1 (>2 fold) at 4 hours post infection as
identified by IPA analysis. D. Same as in C, but for 12 hours post infection. E.
Overrepresentation of transcription factor binding sites (TFBS) found -5kb to +5kb
around the TSS. TFBS that received Z-score values >10 and p-values < 0.01 were
considered to be significant, and are indicated by green circles. All TFBS associated with
the 136 genes associated with differential PAF1 binding are displayed as black circles;
All TFBS associated with a set of 136 randomly selected PAF1 binding genes are shown
as white circles.
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4.4

PAF1 recruitment is correlated with gene expression and Pol II recruitment
Our data on PAF1 binding indicate that the dynamics of PAF1 recruitment on

chromatin during infection is highly specific and is strongly dominated by genes
belonging to type I interferon signaling and hallmark genes of the antiviral response.
Given the important role that the PAF1C plays as a transcription elongation factor, we
hypothesized that PAF1 recruitment to these genes is critical for their expression. To
address this, we utilized two independent approaches to confirm whether an increase in
PAF1 binding at these genes was positively correlated with transcriptional activity of
genes during infection.
The abundance of Pol II at a gene, particularly within its gene body, can be used as
in indicator of transcriptional activity of a gene. We first wanted to determine if PAF1
binding was correlated with Pol II abundance across the genome. To do so, we prepared
Pol II ChIP-sequencing datasets from uninfected and infected cells at 4 hours and 12
hours post infection. In doing so, we found that infection induced changes in PAF1
recruitment were also accompanied by changes with Pol II recruitment to the same genes
(Figures 4.3A and 4.3B). Metagene profiles of Pol II recruitment across genes that
displayed altered PAF1 binding (PAF1-target) against all PAF1-bound genes showed that
Pol II was also specifically recruited to PAF1 dependent, but not PAF1 independent
genes (Figure 4.3C).
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Figure 4.3: Pol II binding correlated to PAF1 binding. A. Cumulative distribution
function (CDF) plots of classes of Pol II or PAF1 bound genes at 4 hours post infection.
The logged fold change in Pol II binding between infected cells at 4 hours post infection
and uninfected cells are shown. Grey line: All Pol II bound genes; Black line: All PAF1
bound genes; Red line: All PAF1 bound genes that display differential recruitment (> 2
fold) during the course of infection. B. Same as for A, except displaying logged fold
change in Pol II binding between infected cells at 12 hours post infection and uninfected
cells. C. Metagene profiles of Pol II and PAF1 binding profiles at all genes that show
differential recruitment of PAF (Solid lines) or all genes that bind PAF1 during infection
(dotted lines). Shown are Pol II (red) and PAF1 (grey) binding profiles at their respective
classes in uninfected cells (top panels) and in infected cells at 4 hours (middle panels)
and 12 hours (lower panels) post infection.

While changes in abundance of PAF1 and Pol II binding at a gene suggest
transcriptional competence, it may not necessarily reflect overall changes in gene
expression. Instead, a myriad of other co-transcriptional processes can also impact the
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formation of functional transcripts. As such, one approach of determining the impact of
PAF1 binding on gene expression changes would be to quantify levels of mature, polyadenylated transcripts in cells. We thus decided to perform microarray analyses on cells
that had been infected with the PR8/∆NS1virus. When we compared changes in fold
expression for PAF1 dependent and PAF1 independent genes, we found that genes that
actively recruited PAF1 during infection tended to show an increase in expression levels
(Figure 4.4). On the other hand, when we considered all PAF1 bound genes across the
genome, the majority of these had more stable expression levels (Figure 4.4) That is, their
cumulative distributions were centered around a Log 2 (fold change in expression) value of
zero.

Figure 4.4: Inducible-recruitment of PAF1 genes correlates to an increase in gene
expression. A. CDF plots of expression changes within different subsets of PAF1 bound
genes at 4 hours post infection. Genes that inducibly recruit PAF1: solid red line, all
genes that bind PAF: solid black line, genes that do not bind PAF1: broken black line,
and all genes: solid grey line B. CDF plots of expression changes within different subsets
of PAF1 bound genes at 12 hours post infection.
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4.5

PAF1-target genes in infection are sensitive to PAF1 depletion
Our data suggest that the expression of the anti-viral genes is related to the active

recruitment of PAF1. This was interesting, in the light of some of our previous
observations that PAF1 depletion during infection specifically inhibited the expression of
anti-viral genes, but not of housekeeping genes. Active recruitment of PAF1 to these
genes might represent a rate limiting step in the activation of the genes that is exacerbated
during PAF1 deficiency. This could account for why PAF1, despite its role as a general
transcription elongation factor, only impacts the infection regulated genes during
infection.
We thus re-did microarray analyses on uninfected and PR8/∆NS1 infected cells
treated either with siRNA against PAF1 (siPAF) or with a control, non-targeting siRNA
(siCtrl). Consistent with our previous results, PAF1 deficiency had a limited impact on
gene expression in uninfected cells, with 46 genes showing greater than 2 fold change.
The expression of housekeeping genes was also stable. Also, as we had shown
previously, the impact of PAF1 deficiency was much greater in infected cells, with a total
of 367 genes displaying siPAF1 sensitivity over the course of infection (Figure 4.5A).
There were two subgroups of siPAF1 sensitive genes. These were (1)genes that were upregulated upon PAF1 depletion, and (2) those that were down-regulated upon PAF1
depletion. Overall, we found that PAF1 had strong impact on about 7.5% infection
regulated genes at 4 hours post infection, and 5.0% of infection regulated genes at 12
hours post infection, indicating that PAF1 depletion only affected a subset of genes
(Figure 4.5A). Consistent with what we observed previously, the genes that were
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sensitive to PAF1 depletion were enriched with inflammatory genes and anti-viral
effector genes (Figure 4.5B).
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Figure 4.5: siPAF1 sensitive genes in infection. A. Overlap of PAF1 sensitive genes
and infection regulated genes at 4h and 12h post infection. B. Top five functional
categories associated with siPAF1 sensitive genes as identified by IPA analysis

We next determined the pattern of PAF1 binding on siPAF1 sensitive genes during
infection. To do so, we cross-referenced our microarray data to our PAF1 ChIP-seq data.
We were able to map 45-50% of our siPAF1 sensitive genes at 4 and 12 hours post
infection to PAF1 bound regions during infection. When we examined PAF1 levels on
these genes however, we saw that there was a direct correlation between genes affected
by PAF1 depletion and its active recruitment during infection (Figures 4.6A and B
middle and right panels). In fact, by 12 hours post infection, PAF1 binding levels at these
genes were significantly higher than other PAF1 bound genes genome-wide (Figure 4.6B,
right panels). In addition, comparison of these loci against genome wide PAF1 bound loci
revealed that the majority of these siPAF1-sensitive loci were initially associated with
lower PAF1 binding levels as compared to that of other genes (Figures 4.6A and B, left
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panels). In contrast, genes that were up-regulated upon PAF1 depletion showed little or
no change in PAF1 binding throughout the infection. The changes in PAF1 binding
associated with these genes could not be attributed to a general loss of PAF1 binding at
other genes, as the levels of PAF1 on the majority of PAF1 bound loci remained constant
throughout infection (Figure 4.6C).
We were concerned that the quantitative aspect of our bioinformatics analysis could
have been skewed due to inherent limitations of our peak-calling program. As such, we
also examined metagene profiles PAF1 binding at siPAF1 sensitive and all genes in the
genome. Consistent with our previous results, we found that siPAF1 sensitive genes were
associated with increasing levels of PAF1 during the course of a normal infection (Figure
4.6D). In contrast, metagene profiles genes throughout the whole genome revealed
limited change in PAF1 binding during infection. Altogether, these data suggest that
siPAF1 sensitive genes tend to actively recruit PAF1 during infection.
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Figure 4.6: PAF1 levels are dynamically regulated in siPAF1 down-regulated genes.
A. CDF plots PAF1 binding intensity at genes that were identified to be dysregulated by
siPAF at 4 hours post infection. Left panel: PAF1 levels at siPAF downregulated (blue),
siPAF upregulated (red) and PAF levels at all genes in uninfected (0h) cells; Middle
panel: PAF1 levels at the same genes at 4 hours post infection; Right panel: PAF1 levels
at the same genes at 12 hours post infection. Note how the amount of PAF associated
with the siPAF downregulated genes shift over time. The overlap between siPAF
sensitive genes and all PAF1 genes is indicated in the venn diagram. B. Same as in A,
except comparing PAF1 binding in genes that were dysregulated by siPAF treatment at
12 hours post infection. C. Overall levels of PAF1 across the genome remains the same
throughout the course of infection. D. Metagene profiles showing PAF1 binding in genes
that are dysregulated by siPAF at 4 hours (left panel) and 12 hours (middle panel) during
infection. The PAF1 binding profiles of all genes is also shown (right panel). For each
class of gene, PAF1 binding levels in uninfected cells are shown as solid grey lines,
whereas PAF1 binding levels for genes at 4 hours post infection and 12 hours post
infection are shown in yellow and green respectively.
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4.6

Conclusions
In summary, we have shown that in contrast to the rest of the genome, PAF1 is

actively recruited to anti-viral and inflammatory genes. PAF1 recruitment to this subset
of genes coincides with the recruitment of Pol II and their expression. We also found that
genes that are sensitive to PAF1 depletion during infection have low initial levels of
PAF1 bound, but actively recruit PAF1 as the infection progresses. We therefore propose
that PAF1 sensitivity is likely to result from an inability to recruit optimal levels of PAF1
to target genes during infection.
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CHAPTER 5: DISCUSSION
Starting from an unbiased bioinformatics screen, we were able to show a novel
means by which influenza virus can use a histone H3K4-like sequence in its NS1 protein
to specifically target inflammatory gene expression. This is achieved through the
inhibition of transcription elongation activity of the PAF1C in host cells. In addition, we
show that the PAF1C is an important regulator of the inflammatory response, and its
active recruitment to anti-viral genes is required for their expression.

5.1

PAF1C and its associated activities are important targets for pathogens
By using chromatinized in vitro transcription assays, we were able to show that the

binding of NS1 to PAF1 was able to block the transcription elongation activity of PAF1.
This corroborated and further explained our in vivo genome-wide analysis of
transcriptional elongation dynamics (GRO-seq) in infected cells, where we saw a defect
in transcription elongation in wild-type NS1 infected cells as compared to deltaPAF1
infected cells. Our results suggest that the NS1 protein specifically targets the
transcription elongation activity of the PAF1C in cells.
However, aside from its role as a transcription elongator, the PAF1C has been
shown to participate in several other co-transcriptional processes. These include
promoting transcription-coupled histone modifications (Hahn et al., 2012; Kim and
Roeder, 2009; Wood et al., 2003) as well as regulation of mRNA 3’ end processing
(Mueller et al., 2004; Nagaike et al., 2011; Nordick et al., 2008; Penheiter et al., 2005;
Rozenblatt-Rosen et al., 2009). For instance, the PAF1C has been shown to impact
monoubiquitylation of histone H2BK120 in human cells, by promoting recruitment of the
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ubiquitin-conjugating enzyme Rad6 and the ubiquitin protein ligase hBre1 to chromatin
(Kim and Roeder, 2009; Wood et al., 2003). Rad6/Bre1 mediated monoubiquitylation of
H2BK120 facilitates H3K4 tri-methylation and H3K79 di-methylation by the Set1/MLL1 and Dot1 complexes respectively (Dover et al., 2002; Kim et al., 2009; Nakanishi et al.,
2009; Sun and Allis, 2002). In turn, these modifications can influence the recruitment
and/or activities that further impact chromatin structure and transcriptional competence of
the gene.
Given the multiple roles that the PAF1C plays in regulating transcription and in
enhancing inflammatory gene transcription, it is no wonder that the complex and its
associated activities are subject to manipulation by several other pathogens besides the
Influenza A virus. Indeed, the human immunodeficiency virus (HIV) TAT protein was
previously shown to recruit the PAF1 complex, along with P-TEFb and other elongation
factors (specifically the super elongation complex, comprising of AFF4, AF9, ELL and
ENL) (Sobhian et al., 2010) to the virus promoter during infection. This was thought to
promote the formation of a permissive chromatin environment and allow viral replication.
In further support of this, independently conducted studies have shown that PAF1 overexpression results in overall reduced levels of pro-viral integration during HIV infection,
highlighting the importance of PAF1 expression in the HIV viral life cycle (Liu et al.,
2011).
Interestingly, the human adenovirus (HAdV) has also been shown to require
PAF1C activity to replicate. This is mediated via the HAdV virulence factor E1A, which
binds to and inhibits Bre1 protein, which, as mentioned previously, also interacts with the
PAF1C. During infection, E1A recruits the PAF1C to the viral genome via Bre1, thus
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promoting viral early gene expression (Fonseca et al., 2013). In support of this,
knockdown of PAF1 results in reduced viral early gene transcription. The interaction of
E1A to Bre1 was also shown to inhibit the expression of IFN and ISGs, suggesting that
Rad6/Bre1 mediated ubiquitylation of H2BK120 was important for the expression of
these genes (Fonseca et al., 2012). Given that Rad6/Bre1 activity is also facilitated by the
PAF1 complex, these data support the notion that the PAF1C and its related activities are
key regulators of the inflammatory response.

5.2

Differential Susceptibility of stress-response genes to PAF1 depletion
We were interested to note that despite the general association of PAF1 with Pol II

genome-wide, only a subset of genes within the cell are sensitive to PAF1 depletion. This
phenomenon was not restricted to our experimental system. In yeast, PAF1 knockout
(PAF1∆) cells behave normally under homeostatic conditions, but are hypersensitive to a
variety of stress-inducing conditions (Betz et al., 2002; Costa and Arndt, 2000; Kim and
Levin, 2011; Squazzo et al., 2002). Altogether, these data suggest that the PAF1C serves
a function in stress-induced gene expression.
Our studies imply that genes that are most sensitive to PAF1 depletion are genes
that have low initial levels of PAF1 bound and require active recruitment of PAF1 to
become active. Reduced or inhibited PAF1 recruitment to these genes by siRNAmediated depletion of PAF1 thus inhibits gene activation. Many of the stress response
genes can impact normal biological processes of the cell, such as protein folding,
translation or pre-mRNA splicing. As such, these genes are tightly regulated and silenced
under homeostatic conditions, since their constitutive activation is could be detrimental to
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the cell. Given the central role of PAF1 in transcription, its recruitment is likely to affect
several regulatory steps in the activation of these genes.
PAF1 has been implicated in several events that control the efficiency of
transcription elongation of its target genes. As mentioned earlier, an important activity of
the PAF1 complex is the promotion of histone H2B ubiquitylation, which has been
shown to be critical for the transcription of several inducible genes (including GAL1,
SUC2 and PHO5) in yeast (Kao et al., 2004). In the absence of ubiquitylated H2b,
transcription of these genes is severely impaired. Also, as mentioned previously, HAdV
mediated inhibition of the hBre1 complex results in reduced H2B ubiquitylation and an
impaired IFN response in infected cells (Fonseca et al., 2012). H2B ubiquitylation may
also affect promoter clearance and release of Pol II into productive elongation. In yeast,
H2B de-ubiquitylation by Ubp8 is required to recruit Ctk kinase complex to the
gene(Henry et al., 2003). In turn, Ctk phosphorylation of the serine 2 in the Pol II CTD
facilitates Pol II entry into productive elongation (Zhou et al., 2009). Given that the
PAF1C facilitates the recruitment and activation of the Rad6/Bre1 complex to
ubiquitinate histone H2B, it may be that this activity contributes to the reliance of stress
induced genes on PAF1C recruitment. It will thus be interesting to investigate how
Rad6/Bre1 and H2B ubiquitylation is affected during infection.
Besides its interactions with histone modifying enzymes such as Rad6/Bre1, the
PAF1C has also been shown to interact with a number of transcription elongation
complexes, including DSIF, FACT, TFIIS and SEC (Super Elongator complex) (Chen et
al., 2009; Dawson et al., 2011; Kim et al., 2010; Qiu et al., 2006; Squazzo et al., 2002).
PAF1C has been shown by several groups to stimulate transcription of target genes
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through cooperative interactions with these complexes. These complexes have all been
implicated in different regulatory steps during inducible transcription. In fact, loss of
PAF1 results in reduced association of DSIF and FACT on chromatin (Mueller et al.,
2004; Pruneski et al., 2011), suggesting that it is required for these factors to maintain
association with their targets and promote transcription.
Finally, the PAF1 complex has been shown to directly stimulate transcription
elongation rates on chromatinized template (Kim et al., 2010). Indeed, our results suggest
that it is this PAF1 dependent activity that is targeted by NS1 during the suppression of
the inflammatory response. This implies that transcription elongation efficiency of stress
response genes is in itself important for their full induction. This has been similarly
suggested in other inducible transcription systems (Danko et al., 2013; Hah et al., 2011).
Further support for the role of transcriptional elongation in the regulation of the stress
response has been shown in studies of a PAF1C independent transcription elongation
factor Elongin A. Elongin A is a component of a multisubunit transcription elongation
complex comprising of Elongin A, Elongin B and Elongin C. Like the PAF1 protein,
previous studies have shown that Elongin A is not generally required for transcription in
vivo under homeostatic conditions (Gerber et al., 2005; Kawauchi et al., 2013). However,
during the induction of the heat shock response, induction of the heat shock responsive
genes ATF3 and HSP70 were abrogated. Taken together, these studies strongly support
the notion that transcription elongation is an important component for the efficient
induction of stress response genes. An important implication of these studies is that
inhibition of transcription elongation activity could allow for a targeted way of
manipulating stress response genes. Given that many diseases are manifested by over-
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activation of stress responses, these findings could have important implications in the
development of therapeutics aimed at balancing the out of control stress response.

5.3

Mechanisms of PAF1C recruitment to target genes
Our data show that the active recruitment of PAF1 to a subset of anti-viral genes

coincides with and is critical for their expression during infection. This is likely to
contribute to their sensitivity to PAF1 depletion during infection. However, the
mechanisms by which PAF1C is recruited to its target genes on chromatin is not well
understood in mammalian cells. In yeast, recruitment of the yeast PAF1C (yPAF1C) to
chromatin is mediated primarily by its yRTF1 and yCDC73 subunits (Amrich et al.,
2012; Warner et al., 2007). yRTF1 interaction with chromatin is thought to be mediated
by a conserved Plus3 domain. Loss of this domain in yRTF1 results in the impaired
chromatin association of yPAF1C (Warner et al., 2007). In addition, yRTF1 has been
shown to play an important role in mediating histone H2B ubiquitylation, and a small
histone modification domain present on the protein is sufficient to substitute the entire
yPAF1C for promoting H2B ubiquitylation in the absence of PAF1(Piro et al., 2012). On
the other hand, yCDC73 was also shown to be important yPAF1C recruitment to genes.
This is thought to be mediated by a Ras-like domain in the C-terminal of yCDC73.
Truncation of almost the entire domain in yCDC73 impairs yPAF1C recruitment to
chromatin without disrupting the integrity of yPAF1C(Amrich et al., 2012). Independent
studies confirmed a role of yCDC73 in binding to the phophorylated C-terminal domain
(CTD) of elongating Pol II and also to the phosphorylated C-terminal region (CTR) of
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yeast Spt5 (subunit of the yeast Spt4/Spt5 complex, and yeast ortholog of the mammalian
DSIF) (Qiu et al., 2012; Qiu et al., 2006).
Another group of candidates that have been implicated in PAF1C recruitment to
chromatin is the bromodomain and ET domain (BET) family of proteins. The BET
proteins are a family of reader proteins that bind to acetylated histones. Members of the
family, which include BRD2, BRD3, BRD4 and BRDT, share similar structural
properties, each comprising of two tandem bromodomain modules, an extra-terminal
domain and a C-terminal domain (Belkina and Denis, 2012). Interestingly, recent
proteomic screens have identified that the PAF1C may interact and function
cooperatively with members of this family (Dawson et al., 2011). In fact, these studies
showed that inhibition of BET binding activity by I-BET, resulted in reduced PAF1
recruitment to chromatin (Dawson et al., 2011). In addition to this, similar to PAF1
depletion, inhibition of BET protein recruitment to chromatin results in the selective
repression of inflammatory genes during lipopolysaccharide (LPS) stimulation of bonemarrow derived macrophages (Hargreaves et al., 2009; Nicodeme et al., 2010). These
studies, taken together with our findings that PAF1 recruitment is essential for the proper
induction of the anti-viral response, suggest that the BET proteins could be critical for
maintaining optimal levels of PAF1C on chromatin. It remains to be seen how the BET
proteins and PAF1C interact to coordinate the transcriptional response in infection.
Finally, a recent study revealed that histone H3 asymmetrically di-methylated on
arginine 17 (H3R17) could promote the recruitment of PAF1C to chromatin(Wu and Xu,
2012). Consistent with our results, this study demonstrated that an unmodified histone H3
tail is sufficient to bind PAF1C, but that this interaction is enhanced upon methylation of
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H3R17. Loss of the CARM1 methyltransferase, the primary mediator of H3R17
methylation, results in greatly reduced PAF1 recruitment to chromatin. In contrast, loss
of depletion of PAF1C components had no impact on H3R17me2a abundance, indicating
that CARM1 and H3R17me2a act upstream of PAF1C. Taken together with our findings
on PAF1, this result not only suggests a potential cross talk between H3K4 and H3R17,
but also strongly implies a role for CARM1 in the control of the inflammatory response.
Indeed, CARM1 has previously been implicated as a co-activator for NF-kB dependent
genes, and was shown to enhance their activities during stimulation (Miao et al., 2006).
Further investigation will be required to uncover the role of the CARM1 and the PAF1C
in regulating the inflammatory response.

5.4

Histone mimicry is a viable strategy for pathogens to manipulate host
processes
This study has demonstrated that histone mimicry can be a viable strategy for

pathogens to modulate host function. We were also able to confirm that the histone H3
protein can interact with PAF1C. Altogether, these data support the idea that the histone
H3 motifs can function as discrete informational units in signaling. It will be interesting
to investigate if other viral pathogens that we found in our in silico screen also carry
functional histone-motifs.
A key feature of the histone tails is their ability to switch between different
functional states via post-translational modifications (see Introduction). Indeed, we show
that PAF1 binding to the histone H3 tails can be abrogated by acetylation, but not
methylation. The same appears to be true for the NS1 histone-like sequence, although we
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were regrettably not able to fully investigate the functional consequences of NS1 or
Histone H3 acetylation and PAF1 binding. However, it may be that in addition to
inhibiting PAF1 activity to suppress the immune response, NS1 could also use the
PAF1C to locate its other binding partners. Indeed, the PAF1C has been shown to bind to
another known NS1 target, the cleavage and polyadenylation factors complex (CPSF)
(Rozenblatt-Rosen et al., 2009) through its CDC73 subunit.
Modification of NS1 could thus play a role in “re-purposing” the NS1 protein, and
allow it to switch between binding partners during infection. For example, both CHD1
and PAF1C, which have been shown to interact with each other (Simic et al., 2003), were
able to bind to the NS1 histone-like sequence, albeit in a modification-dependent ways.
Moreover, there is increased interaction of the NS1 protein with host CHD1 upon
methylation of the NS1 histone-like sequence. Since CHD1 has also previously been
shown to interact with spliceosomal components and impact efficacy of pre-mRNA
splicing (Sims et al., 2007) (in addition to its role as a chromatin remodeler (Tran et al.,
2000)), this could potentially be a way for the virus to gain access to the spliceosome and
impact pre-mRNA splicing in the host cell (Lu et al., 1994; Qiu et al., 1995; Wang and
Krug, 1998). NS1 interaction with the host splicing machinery may also play an
important role in regulating viral mRNA splicing, which is also important for the viral
lifecycle (Chua et al., 2013).
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5.5

Short linear motifs occurring in the NS1 C-terminal domain are virulence
factors
The NS1 C-terminal tail domain has previously been implicated as a virulence

factor for some avian influenza A viral isolates. In fact, several studies have shown that
the majority of NS1 sequences derived from these viruses carry PDZ ligand (PL) motifs
(consensus: X-[S/T]-X-V COOH ; where X represents any amino acid, and COOH
represents the C-terminal) in their C-terminal domain (Figure 5.1) (Obenauer et al.,
2006). PDZ domains are protein-protein recognition motifs that are found widely in
proteins involved in cell-signaling. These proteins specifically recognize and bind to
short 4 to 5 amino acid long PL motifs, which are almost always found at the C-terminus
of the protein. Avian PL motifs (including EPEV, ESEV) are not commonly observed in
human isolates of virus, but have been strictly associated with several highly pathogenic
human isolates. In particular, NS1 sequences from the H5N1 1997 and H5N1 2003
human pandemic viruses were shown to contain avian-like C-terminal PL domains ESEV
and EPEV respectively (Jackson et al., 2008; Obenauer et al., 2006; Thomas et al., 2011).
These PL motifs were necessary for the interaction of the virus with PDZ proteins such as
Dlg, scribble (Golebiewski et al., 2011), Magi-I (Kumar et al., 2012). In particular, H5N1
NS1 PL-mediated binding to scribble and Dlg1 was required to protect infected cells
from apoptosis, thus contributing to viral virulence (Golebiewski et al., 2011).
On the other hand, common-circulating, low pathogenic human viruses
predominantly contain PL motif sequences RSKV (H3N2 isolates), and RSEV (H1N1
isolates). Despite being canonical PLs, these motifs do not appear to bind well to known
PDZ domain containing proteins (Obenauer et al., 2006; Thomas et al., 2011). In fact,
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viral virulence can be increased if these “human” PL motifs are replaced with those
derived from avian isolates. Despite this, overall loss of the NS1 C-terminal tail from
low-pathogenic viruses still results in viral attenuation(Jackson et al., 2008). This
suggests that the C-terminal domain of NS1 is an important contributor to the overall
virulence of the virus, although its specific function remains unknown. In this study, we
show that the H3N2 virus utilizes its NS1 C-terminal domain to interact with host PAF1C
instead. This is mediated by a histone H3-like motif A-R-S/T-K also present in the Cterminal domain. NS1 interaction with PAF1 was necessary for the virus to repress the
host immune response, and replicate well. Altogether, these studies confirm the role of
the role of the Influenza A NS1 C-terminal domain as an important virulence factor that
as likely evolved to interact in a species-specific way with pivotal regulators of the cell
response.

5.6

Influenza Adaptation and Virulence
It is interesting to note that the histone H3-like sequence is predominantly found in

the low-pathogenic human influenza viruses. Historically, low virulence has often been
argued as a way for parasites to avoid overexploitation of the host resources, and improve
transmissibility (Frank, 1996). This theory postulates that given enough time, pathogens
would eventually become avirulent and achieve symbiosis with their hosts. In the light of
this, it is tempting to speculate that the interaction of the H3N2 NS1 constitutes an
adaptation of the virus to maintain a virus pool circulating in the human population.
However, the truth is that virulence of the influenza virus is a multi-genic trait that
is not dependent on NS1 alone (Fukuyama and Kawaoka, 2011; Tscherne and Garcia95

Sastre, 2011; Wasilenko et al., 2008). Several studies have indicated that influenza viral
proteins are functionally linked, and exert epistatic effects on one another (Kaverin et al.,
2000; Twu et al., 2007). In fact, NS1 protein function has been shown to be tightly linked
to the identity of viral polymerase genes(Kuo and Krug, 2009). Notably, artificially
engineering reassortant viruses, where the cognate NS segment is replaced with a NS
gene from more virulent strains of virus, has been shown to have minimal effects on viral
pathogenicity (Kuo and Krug, 2009; Sarmento et al., 2010; Shelton et al., 2012).
Furthermore, large scale sequencing analysis of avian influenza isolates has also
indicated that many of the core influenza protein co-segregate with one another
(Obenauer et al., 2006).
The lower pathogenicity of the human influenza viruses (including H3N2 and
H1N1) also do not necessarily indicate a trend towards avirulence and symbiosis of the
Influenza A virus within human populations. This model assumes that viral transmission
is a function of host mortality (i.e. viruses that kill their hosts quickly have a poorer
chance of survival), while ignoring other factors, such as the geographical distribution of
host populations, or potential competition between related strains of the same virus. In
fact, several groups have argued that local distributions and intrinsic susceptibility of host
populations are more important factors for determining viral virulence (Boots and Sasaki,
1999; Frank and Schmid-Hempel, 2008; Palese and Wang, 2011; Pfennig, 2001; Wild et
al., 2009). The correlation between NS1-PAF1 interaction and poorer viral virulence
could indeed be an evolutionary step towards achieving optimal viral fitness, but must
ultimately be considered in the context of NS1 interactions with other viral and host
proteins, as well as pathogen specialization within host populations.
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